Other and unspecified rosacea

L12_ROSACEANAS

rosacea: a chronic skin condition characterized by facial redness, small and superficial dilated blood vessels on facial skin, papules, pustules, and swelling.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L71.8, L71.9 Hospital discharge: ICD-9 — 6953A Cause of death: ICD-10 — L71.8, L71.9 Cause of death: ICD-9 — 6953A 2 out of 7 registries used, show all original rules.	4326
4. Check minimum number of events None	4326
5. Include endpoints None	4326
6. Filter based on genotype QC (FinnGen only)	3954

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	L12_ROSACEANAS
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L71[8-9]
HD_ICD_9	6953A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L71[8-9]
COD_ICD_9	6953A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified rosacea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18076	11991	6018
Only index persons	17470	11760	5710
Unadjusted period prevalence (%)
Whole population	0.28	0.34	0.17
Only index persons	0.36	0.43	0.22
Median age at first event (years)
Whole population	54.55	52.63	58.42
Only index persons	54.37	52.49	58.23

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3954	2815	1139
Unadjusted period prevalence (%)	0.86	1.00	0.52
Median age at first event (years)	55.98	53.51	62.07

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4052: Matched controls
40520

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E0000UV, ,

ATC

3.5

319.2

2486

12746

J01AA07

ATC

tetracycline; systemic

7.0

307.7

1657

3624

D06BX01

ATC

metronidazole; topical

29.0

307.7

2674

2545

L71

ICD-10 Finland

Rosacea

18.9

307.7

651

407

D10BA01

ATC

isotretinoin; oral

9.7

307.7

839

1065

J01AA04

ATC

lymecycline; systemic

10.1

307.7

1787

2936

L71.8

ICD-10 Finland

Other rosacea

409.4

307.7

2154

112

D10AX03

ATC

azelaic acid; topical

5.5

307.7

719

1518

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.7

307.7

868

1859

L71.9

ICD-10 Finland

Rosacea, unspecified

197.1

307.7

2533

340

XQ802

NOMESCO Finland

Epicutan test

6.6

276.2

480

812

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.3

271.6

1461

5876

L71.0

ICD-10 Finland

Perioral dermatitis

10.8

214.1

236

230

XQ848

NOMESCO Finland

Dermatological photography

7.1

194.8

303

453

L70.0

ICD-10 Finland

Acne vulgaris

12.5

190.5

190

159

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.6

186.6

716

2277

E000001, ,

ATC

2.8

174.2

1152

5015

L57.0

ICD-10 Finland

Actinic keratosis

3.6

171.8

657

2078

L73.8

ICD-10 Finland

Other specified follicular disorders

19.1

134.5

106

XQ800

NOMESCO Finland

Prick test

3.4

131.6

529

1713

D07AB02

ATC

hydrocortisone butyrate; topical

2.3

131.1

1525

8447

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

7.0

131.0

204

304

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

6.7

125.9

205

320

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

9.4

125.4

152

168

D07AC01

ATC

betamethasone; topical

2.2

121.4

1791

10835

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

110.6

744

3189

TQW80

NOMESCO Finland

Local dermatologic skincare

5.6

107.1

208

386

H01.0

ICD-10 Finland

Blepharitis

3.2

104.0

466

1602

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

99.4

2008

13336

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.3

97.4

200

390

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.1

94.4

1131

6186

XQ845

NOMESCO Finland

Dermatoscopy

5.9

90.8

167

294

L71.1

ICD-10 Finland

Rhinophyma

232.7

88.8

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.4

87.9

694

3180

D07AC13

ATC

mometasone; topical

2.0

87.4

1362

8167

D07XC01

ATC

betamethasone; topical

2.5

84.3

618

2734

D07AB08

ATC

desonide; topical

2.5

81.0

570

2471

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.3

79.0

163

319

S01GX01

ATC

cromoglicic acid; ophthalmic

2.1

78.7

1032

5781

ZXC50

NOMESCO Finland

Cryotherapy

4.5

78.3

194

443

L73.2

ICD-10 Finland

Hidradenitis suppurativa

15.1

76.0

ZXC12

NOMESCO Finland

Pulse colorlaser

19.3

75.4

D07AD01

ATC

clobetasol; topical

2.1

74.7

834

4389

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.5

74.6

265

785

H02AB06

ATC

prednisolone; systemic

1.8

73.4

2080

14888

E0001A1, ,

ATC

5.3

72.3

147

284

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

7.4

69.1

101

140

R06AX27

ATC

desloratadine; oral

1.8

68.2

1390

8950

L04AX01

ATC

azathioprine; systemic

3.4

67.0

256

794

D07AA02

ATC

hydrocortisone; topical

2.2

66.9

667

3344

E000002, ,

ATC

2.4

66.9

545

2512

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

7.4

66.1

132

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

63.6

1268

8074

L73.9

ICD-10 Finland

Follicular disorder, unspecified

14.4

63.0

L20.0

ICD-10 Finland

Besnier prurigo

2.6

62.1

409

1708

D10AF01

ATC

clindamycin; topical

3.1

61.3

275

939

S29

ICPC

Skin symptom/complaint other

1.9

60.9

946

5551

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.2

59.8

244

787

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.8

59.5

1353

8923

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.6

59.4

389

1619

L93.0

ICD-10 Finland

Discoid lupus erythematosus

9.9

58.1

H00.1

ICD-10 Finland

Chalazion

3.2

56.7

237

776

R06AE07

ATC

cetirizine; oral

1.7

56.2

1939

14277

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.7

53.3

306

1192

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

12.5

53.0

TQW99

NOMESCO Finland

Other minor procedure on skin

3.0

52.9

243

840

UJF32

NOMESCO Finland

Coloscopy

1.8

52.5

1087

6927

D02AE01

ATC

carbamide; topical

2.6

52.4

322

1298

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.3

51.5

453

2146

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

50.2

979

6119

L21.0

ICD-10 Finland

Seborrhoea capitis

6.2

49.8

139

D02AX

ATC

Other emollients and protectives

3.5

49.4

171

497

J02AC01

ATC

fluconazole; systemic

1.6

48.6

1813

13449

L04AX03

ATC

methotrexate; systemic

2.2

48.4

476

2355

D11AH02

ATC

pimecrolimus; topical

10.5

48.2

J01DB01

ATC

cefalexin; oral

1.9

47.7

3387

29579

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

46.4

1000

6409

P01BA02

ATC

hydroxychloroquine; oral

2.2

45.6

411

1962

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

13.3

44.3

SPAT1153

SPAT

Removal of sutures

1.7

43.6

1233

8475

J01AA02

ATC

doxycycline; systemic

1.7

42.9

3186

27577

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.6

42.8

254

1004

S18

ICPC

Laceration/cut

1.6

42.3

1885

14421

M79.6

ICD-10 Finland

Pain in limb

1.6

41.5

1879

14408

D05BB02

ATC

acitretin; oral

3.8

40.5

123

327

J04BA02

ATC

dapsone; oral

9.5

39.8

L50.3

ICD-10 Finland

Dermatographic urticaria

3.9

39.4

117

306

A02BC05

ATC

esomeprazole; systemic

1.5

38.3

1667

12594

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

37.9

1829

14127

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.9

37.6

181

641

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

37.6

309

1417

L04AA06

ATC

mycophenolic acid; systemic

3.9

37.4

112

295

L30.3

ICD-10 Finland

Infective dermatitis

2.9

36.9

179

637

R06AE09

ATC

levocetirizine; oral

1.8

36.8

641

3836

L70.9

ICD-10 Finland

Acne, unspecified

9.4

36.2

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

36.2

803

5142

E000006, ,

ATC

2.3

36.2

301

1387

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

35.6

1081

7493

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

4.1

35.2

249

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.7

35.0

175

L70

ICD-10 Finland

Acne

4.7

35.0

179

S01XA18

ATC

ciclosporin; ophthalmic

5.7

34.8

116

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

34.7

785

5048

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.0

34.2

151

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

33.8

723

4578

E000007, ,

ATC

2.4

33.7

248

1084

J05AB01

ATC

aciclovir; systemic

1.6

33.3

931

6308

M25.5

ICD-10 Finland

Pain in joint

1.5

33.1

1423

10627

R03AC02

ATC

salbutamol; inhalant

1.5

33.0

2238

18344

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.1

32.9

226

A02BC02

ATC

pantoprazole; systemic

1.5

32.2

2751

23579

R06.0

ICD-10 Finland

Dyspnoea

1.6

32.2

1061

7466

D05AX52

ATC

calcipotriol, combinations; topical

2.3

31.6

238

1051

J01FF01

ATC

clindamycin; systemic

1.6

31.3

1055

7454

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

31.1

1505

11481

F29

ICPC

Eye symptom/complaint other

1.9

31.1

467

2662

S99

ICPC

Skin disease other

3.3

30.8

117

361

A02BC03

ATC

lansoprazole; oral

1.5

30.6

1099

7869

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

30.4

469

2694

L70.8

ICD-10 Finland

Other acne

32.8

30.0

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

29.8

311

1565

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

29.4

385

2098

L30.8

ICD-10 Finland

Other specified dermatitis

2.9

29.2

144

517

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

29.2

1306

9776

H02AB04

ATC

methylprednisolone; systemic

1.7

29.2

586

3634

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.3

29.0

111

344

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.5

28.9

157

A02BC01

ATC

omeprazole; systemic

1.5

28.7

1033

7381

SPAT1310

SPAT

Counselling related to known health issue

1.5

28.7

1184

8710

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

28.4

112

354

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

28.3

2706

23375

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

28.3

1560

12150

S21

ICPC

Skin texture symptom/complaint

1.7

28.3

616

3903

H00.00

ICD-10 Finland

Hordeolum

2.3

28.2

220

986

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.6

28.0

145

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

28.0

505

3037

CBB00

NOMESCO Finland

Excision of chalazion

4.1

27.9

187

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

27.8

1622

12759

L72.1

ICD-10 Finland

Trichilemmal cyst

2.3

27.7

222

1006

R01AD12

ATC

fluticasone furoate; nasal

1.5

26.3

1321

10072

J01DA01

ATC

[U] cefalexin

1.4

26.0

2397

20391

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

25.9

475

2868

SPAT1301

SPAT

No procedures

1.5

25.8

1127

8351

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

25.8

211

964

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

25.8

2899

25565

R06AX22

ATC

ebastine; oral

1.6

25.8

728

4909

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.0

25.8

111

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

25.8

429

2518

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

25.6

1102

8143

R03DC03

ATC

montelukast; oral

1.6

25.5

700

4690

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

25.2

1062

7806

Z01.2

ICD-10 Finland

Dental examination

1.4

25.2

1882

15390

E000003, ,

ATC

2.3

24.9

184

806

D11AH01

ATC

tacrolimus; topical

4.4

24.8

143

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

24.7

515

3216

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.3

24.7

191

853

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

24.6

1482

11651

R01AD58

ATC

fluticasone, combinations; nasal

1.5

24.6

1060

7823

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

5.4

24.5

R05

ICD-10 Finland

Cough

1.5

24.3

860

6093

SPAT1263

SPAT

Sampling

1.4

24.0

1545

12272

S08

ICPC

Skin colour change

2.1

24.0

231

1126

R01AD09

ATC

mometasone; nasal

1.4

24.0

1836

15030

J01FA01

ATC

erythromycin; systemic

1.7

24.0

550

3521

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.9

24.0

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

23.8

1168

8827

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.9

23.6

179

J01MA02

ATC

ciprofloxacin; systemic

1.4

23.5

1402

10979

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

23.4

1054

7831

J01FA10

ATC

azithromycin; systemic

1.4

23.4

2276

19375

G47.3

ICD-10 Finland

Sleep apnoea

1.5

23.2

854

6091

J01FA06

ATC

roxithromycin; oral

1.4

23.2

1532

12208

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.9

23.1

306

1671

N02AX02

ATC

tramadol; systemic, rectal

1.4

23.0

1598

12835

J02AC02

ATC

itraconazole; systemic

1.6

23.0

707

4850

L50.9

ICD-10 Finland

Urticaria, unspecified

2.3

22.9

176

783

B07.9

ICD-10 Finland

Verruca simplex

2.4

22.8

157

666

SPAT1312

SPAT

General health counselling

1.4

22.8

1154

8759

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

22.6

1040

7749

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

22.6

267

1404

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

22.5

328

1847

D06BB10

ATC

imiquimod; topical

2.1

22.1

212

1033

SPAT1260

SPAT

Consultation of another employee

1.6

22.1

632

4263

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

3.9

22.0

170

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

21.8

383

2279

L04AD01

ATC

ciclosporin; systemic

3.2

21.2

277

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

21.1

1429

11387

H15.1

ICD-10 Finland

Episcleritis

3.2

21.0

258

R60.0

ICD-10 Finland

Localized oedema

1.6

21.0

474

3018

6953A

ICD-9 Finland

Erythematous conditions, Rosacea[ROSACEA]

+∞

20.8

R06AX13

ATC

loratadine; oral

1.6

20.8

600

4049

L01XX05

ATC

hydroxycarbamide; oral

4.0

20.8

150

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

20.7

411

2528

H02AB07

ATC

prednisone; oral

1.6

20.7

505

3276

N03AX12

ATC

[U] gabapentin; oral

1.6

20.6

611

4149

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

20.4

732

5179

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

3.7

20.4

175

R51.80

ICD-10 Finland

Headache

1.5

20.3

639

4394

H16.0

ICD-10 Finland

Corneal ulcer

2.1

20.3

208

1038

N02BE01

ATC

paracetamol; systemic, rectal

1.6

20.3

3562

33228

H16.9

ICD-10 Finland

Keratitis, unspecified

3.1

20.3

274

M01AH05

ATC

etoricoxib; oral

1.4

20.2

2480

21675

L30.0

ICD-10 Finland

Nummular dermatitis

2.3

20.1

158

710

L01

ICPC

Neck symptom/complaint

1.5

20.0

680

4753

G44.2

ICD-10 Finland

Tension-type headache

1.6

20.0

567

3811

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

4.4

19.9

112

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

19.7

131

547

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.4

19.7

213

K30

ICD-10 Finland

Functional dyspepsia

1.6

19.5

464

2991

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

19.3

2156

18506

L50.8

ICD-10 Finland

Other urticaria

2.9

19.1

316

F03

ICPC

Eye discharge

1.8

19.1

285

1615

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

19.1

296

1697

S01GX05

ATC

lodoxamide; ophthalmic

3.3

19.1

222

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

19.0

433

2758

A07EA06

ATC

budesonide; oral, local oral

2.2

19.0

156

715

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

19.0

289

1648

D45

ICD-10 Finland

Polycythaemia vera

4.5

18.9

104

S06

ICPC

Rash localized

2.0

18.9

211

1088

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

18.8

465

3022

WZC00, ,

SPAT

1.5

18.8

566

3850

L21

ICD-10 Finland

Seborrhoeic dermatitis

3.0

18.8

271

J05AB11

ATC

valaciclovir; oral

1.5

18.7

579

3963

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

18.7

722

5176

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

18.6

265

1480

N03AX16

ATC

[U] pregabalin

1.4

18.5

842

6229

R01AD08

ATC

fluticasone; nasal

1.4

18.5

1113

8652

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

18.4

964

7312

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.9

18.4

290

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

18.4

232

1247

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

18.3

298

1733

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

18.2

2003

17085

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

18.2

967

7353

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

18.1

305

1791

ZY010

NOMESCO Finland

Hospital outpatient

2.0

18.1

202

1041

SFA20

NOMESCO Finland

Two-surface restoration

1.3

17.8

2301

20069

L04AA01

ATC

[U] ciclosporin

3.4

17.8

192

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

17.7

860

6434

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

17.6

1382

11192

L17

ICPC

Foot/toe symptom/complaint

1.4

17.6

1160

9139

C07AA05

ATC

propranolol; systemic

1.4

17.6

777

5711

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

17.5

411

2636

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

17.5

179

893

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.5

17.5

110

448

SDA03

NOMESCO Finland

Periodontal treatment

1.3

17.5

1600

13255

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

17.5

103

407

L43.8

ICD-10 Finland

Other lichen planus

2.8

17.4

299

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

2.6

17.4

384

A07EC02

ATC

mesalazine; oral, rectal

2.0

17.4

202

1055

K50.8

ICD-10 Finland

Other Crohn disease

3.2

17.3

215

SFA10

NOMESCO Finland

One-surface restoration

1.3

17.3

2128

18393

C01CA24

ATC

epinephrine; parenteral

1.8

17.2

260

1478

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

17.1

287

1683

L04AB04

ATC

adalimumab; parenteral

2.5

17.1

103

411

D06BX02

ATC

ingenol mebutate; topical

3.6

17.1

153

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

17.1

135

609

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

3.2

17.1

217

R52.9

ICD-10 Finland

Pain, unspecified

1.6

17.1

398

2549

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

17.0

499

3372

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

17.0

372

2345

I73.0

ICD-10 Finland

Raynaud syndrome

2.8

16.9

293

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

16.9

260

1487

R53

ICD-10 Finland

Malaise and fatigue

1.4

16.9

948

7263

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.4

16.9

118

505

R05

ICPC

Cough

1.4

16.8

952

7306

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.6

16.7

151

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

16.6

301

1804

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

16.6

163

802

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.3

16.6

125

553

R03BA08

ATC

ciclesonide; inhalant

1.7

16.6

344

2139

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

16.6

1938

16591

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

16.5

228

1261

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

16.5

221

1211

P01AB01

ATC

metronidazole; oral, rectal

1.3

16.5

1551

12871

UKC02

NOMESCO Finland

Cystoscopy

1.5

16.4

486

3292

R06AX26

ATC

fexofenadine; oral

1.7

16.3

284

1684

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

16.2

173

877

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

16.2

211

1145

L20

ICD-10 Finland

Atopic dermatitis

2.3

16.2

127

571

D07AC14

ATC

methylprednisolone aceponate; topical

2.0

16.2

179

919

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.1

2272

19929

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

7.1

16.1

M54.5

ICD-10 Finland

Low back pain

1.3

15.8

1414

11628

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

5.2

15.8

R42

ICD-10 Finland

Dizziness and giddiness

1.4

15.7

821

6206

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

7.2

15.7

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.5

15.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

15.6

493

3382

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.8

15.6

222

1240

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

15.6

531

3702

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

15.6

296

1798

L03

ICPC

Low back symptom/complaint

1.4

15.6

1130

9004

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

15.5

255

1487

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

15.5

258

1510

M79.1

ICD-10 Finland

Myalgia

1.5

15.4

595

4252

L01BC02

ATC

fluorouracil; systemic, topical

4.6

15.4

D06AX01

ATC

fusidic acid; topical

1.7

15.3

322

2008

N06AX11

ATC

mirtazapine; oral

1.3

15.3

1267

10290

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.8

15.3

227

1284

Z00.0

ICD-10 Finland

General medical examination

1.4

15.3

672

4921

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

15.3

341

2159

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

7.0

15.3

S01

ICPC

Pain/tenderness of skin

1.9

15.2

186

989

L13

ICPC

Hip symptom/complaint

1.4

15.2

723

5371

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.7

15.1

289

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

15.0

1049

8300

127

Kela drug reimbursment

Transplant complication

3.1

15.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

14.9

689

5091

H93.1

ICD-10 Finland

Tinnitus

1.7

14.8

264

1575

C03CA01

ATC

furosemide; systemic

1.4

14.8

878

6770

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

14.8

138

667

D82

ICPC

Teeth/gum disease

1.3

14.7

1427

11843

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

14.7

137

662

D01AE16

ATC

amorolfine; topical

1.6

14.6

399

2650

A02BA02

ATC

ranitidine; systemic

1.4

14.6

636

4646

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

14.6

1132

9096

N06AX21

ATC

duloxetine; oral

1.5

14.6

462

3171

G03HB01

ATC

cyproterone and estrogen; oral

1.6

14.6

378

2482

J01DA09

ATC

[U] cefadroxil

1.4

14.6

957

7497

SCA02

NOMESCO Finland

Preventive oral health care

1.6

14.5

351

2267

-1, ,

NOMESCO Finland

1.3

14.4

1202

9754

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

14.4

1049

8344

A01AB09

ATC

miconazole; local oral

1.7

14.4

290

1788

L15

ICPC

Knee symptom/complaint

1.4

14.4

946

7407

S87

ICPC

Dermatitis/atopic eczema

2.4

14.4

415

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

14.4

344

2215

SPAT1058

SPAT

PEF monitoring instruction

1.7

14.3

282

1729

M04AA01

ATC

allopurinol; systemic

1.6

14.3

363

2371

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

5.5

14.3

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

14.2

276

1686

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

14.2

1612

13644

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

14.2

1756

15034

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.8

14.1

111

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

14.0

1411

11747

L20.8

ICD-10 Finland

Other atopic dermatitis

3.1

14.0

185

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

14.0

946

7437

XPX04

NOMESCO Finland

Angioscopy

5.8

14.0

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

14.0

436

2981

F02

ICPC

Red eye

1.9

13.9

170

905

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.4

13.9

379

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.0

13.9

150

765

A98

ICPC

Health maint/preventive medicine

2.0

13.9

3931

38115

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

13.8

164

865

F01

ICPC

Eye pain

2.2

13.7

120

565

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.7

1606

13633

N02BF01

ATC

gabapentin; oral

1.5

13.7

397

2673

S01GX08

ATC

ketotifen; ophthalmic

1.8

13.6

189

1048

S01GX02

ATC

levocabastine; ophthalmic

1.8

13.6

225

1315

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.3

13.6

433

M03BX02

ATC

tizanidine; oral

1.3

13.5

2409

21554

L01BA01

ATC

methotrexate; systemic

2.0

13.5

138

690

SPAT1325

SPAT

Vaccination

1.3

13.5

1079

8689

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.7

13.5

266

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

13.5

111

511

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

13.4

104

467

R03BA02

ATC

budesonide; inhalant

1.4

13.4

654

4872

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

13.4

641

4759

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

13.3

228

1345

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

13.3

274

1700

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.8

13.2

229

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

13.2

180

993

D05AX02

ATC

calcipotriol; topical

2.1

13.2

130

642

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

13.2

653

4876

R03BA01

ATC

beclometasone; inhalant

1.5

13.1

493

3498

M48.0

ICD-10 Finland

Spinal stenosis

1.5

13.1

396

2687

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.2

13.1

161

C03DA01

ATC

spironolactone; oral

1.5

13.1

377

2532

J01FA09

ATC

clarithromycin; systemic

1.3

13.1

1155

9425

L40

ICD-10 Finland

Psoriasis

2.5

13.1

335

A02BC04

ATC

rabeprazole; oral

1.6

13.1

336

2201

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

12.9

1100

8925

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

12.9

221

1304

R03AC03

ATC

terbutaline; inhalant

1.5

12.9

499

3561

L30.4

ICD-10 Finland

Erythema intertrigo

2.8

12.8

228

L08

ICPC

Shoulder symptom/complaint

1.4

12.8

854

6690

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

12.7

387

2630

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.8

12.7

223

L40.8

ICD-10 Finland

Other psoriasis

3.8

12.7

101

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

12.7

303

1951

R01AD01

ATC

beclometasone; nasal

1.4

12.7

566

4148

C09CA06

ATC

candesartan; oral

1.3

12.6

879

6924

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

12.6

302

1944

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

12.6

148

777

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

12.6

265

1652

G01AA10

ATC

clindamycin; vaginal

1.4

12.6

591

4368

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.9

12.6

197

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.5

1600

13684

L63.8

ICD-10 Finland

Other alopecia areata

17.3

12.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

12.5

758

5847

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

12.5

133

676

Z3231

NOMESCO Finland

Registered nurse

1.3

12.4

909

7215

R96

ICPC

Asthma

1.5

12.4

366

2473

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

2.8

12.3

216

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

12.3

466

3311

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

12.3

115

557

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

12.3

473

3373

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

12.2

1820

15841

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

12.2

2766

25334

M01AE02

ATC

naproxen; oral, rectal

1.3

12.2

2127

18867

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

12.2

1008

8137

H16.2

ICD-10 Finland

Keratoconjunctivitis

3.6

12.1

109

M01AC06

ATC

meloxicam; systemic, rectal

1.3

12.1

1306

10919

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

12.1

691

5275

XQ899

NOMESCO Finland

Other assessment of skin

4.6

12.1

KMAK, ,

NOMESCO Finland

1.3

12.1

1919

16828

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

12.1

193

1118

C07AB07

ATC

bisoprolol; oral

1.3

12.0

1604

13768

F72

ICPC

Blepharitis/stye/chalazion

2.2

12.0

443

Z94.0

ICD-10 Finland

Kidney transplant status

3.3

12.0

134

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.0

872

6911

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

11.9

1266

10558

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

11.9

281

1803

L04AD02

ATC

tacrolimus; systemic

3.3

11.9

130

XX9XE

NOMESCO Finland

Other ultrasound examination

3.2

11.9

140

L85.3

ICD-10 Finland

Xerosis cutis

3.1

11.8

151

M79.7

ICD-10 Finland

Fibromyalgia

1.9

11.8

149

803

K07.60

ICD-10 Finland

Snapping jaw

1.7

11.8

206

1224

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

11.8

206

1224

WZC30

NOMESCO Finland

Teaching

1.4

11.8

581

4329

J45

ICD-10 Finland

Asthma

1.5

11.7

385

2658

A46

ICD-10 Finland

Erysipelas

1.5

11.7

449

3196

J01EA01

ATC

trimethoprim; systemic

1.3

11.7

932

7477

R03BA05

ATC

fluticasone; inhalant

1.4

11.7

640

4851

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.5

11.7

280

Z71.8

ICD-10 Finland

Other specified counselling

1.3

11.7

1263

10553

R21

ICPC

Throat symptom/complaint

1.3

11.7

763

5947

R04.0

ICD-10 Finland

Epistaxis

1.7

11.7

235

1450

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

11.6

506

3687

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

11.6

319

2120

D01BA02

ATC

terbinafine; oral

1.3

11.5

846

6705

M77.4

ICD-10 Finland

Metatarsalgia

1.6

11.5

242

1509

L56.4

ICD-10 Finland

Polymorphous light eruption

4.2

11.5

R74

ICPC

Upper respiratory infection acute

1.3

11.5

1253

10475

D05AX03

ATC

calcitriol; topical

2.9

11.4

175

R08

ICPC

Nose symptom/complaint other

1.9

11.4

133

698

A07AA02

ATC

nystatin; oral

1.7

11.3

194

1146

R13

ICD-10 Finland

Dysphagia

1.6

11.3

246

1548

SBB10

NOMESCO Finland

Dental impressions

1.7

11.3

225

1385

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.1

11.2

104

502

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.2

384

2674

G50.1

ICD-10 Finland

Atypical facial pain

2.4

11.2

329

R02

ICPC

Shortness of breath/dyspnoea

1.4

11.1

457

3294

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

11.1

218

1337

A01AB04

ATC

amphotericin B; local oral

1.9

11.0

147

806

R51

ICD-10 Finland

Headache

1.7

11.0

217

1331

L60.0

ICD-10 Finland

Ingrowing nail

1.8

11.0

149

821

C10AC01

ATC

colestyramine; oral

2.1

11.0

102

493

SPAT1216

SPAT

Assessment of functional ability

1.4

10.9

470

3417

ZXC10

NOMESCO Finland

Use of laser

2.3

10.9

345

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.1

10.9

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.8

10.8

166

950

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

10.8

362

2509

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.9

10.8

130

690

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

10.8

420

2998

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

10.8

207

1262

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.4

10.8

316

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.7

602

4579

L12

ICPC

Hand/finger symptom/complaint

1.4

10.7

626

4793

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

10.6

161

919

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

10.6

174

1016

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

10.6

393

2779

R01AD11

ATC

triamcinolone; nasal

1.5

10.6

304

2040

L84

ICD-10 Finland

Corns and callosities

2.0

10.6

118

610

S04

ICPC

Lump/swelling localized

1.5

10.6

388

2738

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

10.6

455

3308

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

10.5

206

1262

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

10.5

775

6140

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

10.5

259

1681

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

10.5

330

2259

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

10.4

410

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

10.4

644

4974

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

10.3

172

1009

L70.1

ICD-10 Finland

Acne conglobata

32.6

10.3

H13

ICPC

Plugged feeling ear

1.4

10.3

635

4898

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

10.3

732

5767

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

10.3

334

2301

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

10.2

108

548

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

10.2

394

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

10.2

152

863

B35.1

ICD-10 Finland

Tinea unguium

1.6

10.2

233

1484

UDC00

NOMESCO Finland

Ear microscopy

1.6

10.2

239

1533

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

10.1

1933

17173

R4110, ,

SPAT

1.4

10.1

482

3566

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.4

10.1

282

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

10.1

391

2788

S01GX09

ATC

olopatadine; ophthalmic

2.0

10.1

108

551

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

10.1

453

3319

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

10.0

134

736

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.0

10.0

145

L66.1

ICD-10 Finland

Lichen planopilaris

40.2

10.0

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

9.9

264

1742

D07XB05

ATC

dexamethasone; topical

2.1

9.9

425

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

9.9

1212

10243

R01AD05

ATC

budesonide; nasal

1.5

9.8

263

1738

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

5.1

9.8

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

9.8

292

1977

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

9.8

156

905

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.7

1562

13604

R50.9

ICD-10 Finland

Fever, unspecified

1.4

9.7

495

3705

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

9.6

1097

9181

D11AH05

ATC

dupilumab; topical

5.3

9.6

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

9.6

130

717

J01MA14

ATC

moxifloxacin; systemic

1.5

9.6

292

1984

J01CA04

ATC

amoxicillin; systemic

1.3

9.6

3143

29558

SPAT1254

SPAT

Administration of medicine

1.4

9.6

434

3182

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.6

924

7578

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.6

9.5

QXA05

NOMESCO Finland

Skin division, unspecified location

4.6

9.5

D10AD01

ATC

tretinoin; topical

2.2

9.5

360

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.2

9.4

348

R09

ICPC

Sinus symptom/complaint

1.5

9.4

316

2190

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

9.4

221

1417

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

9.4

484

3624

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

9.4

232

1506

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

9.4

135

759

QAA30

NOMESCO Finland

Electrocoagulation of skin of head or neck

30.1

9.4

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.0

9.4

489

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

4.4

9.3

H57.1

ICD-10 Finland

Ocular pain

1.8

9.3

147

850

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

9.3

479

3588

EB1VA, ,

NOMESCO Finland

1.3

9.3

660

5192

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

9.3

505

3816

N76.0

ICD-10 Finland

Acute vaginitis

1.5

9.3

247

1631

J46

ICD-10 Finland

Status asthmaticus

2.0

9.3

104

540

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

9.2

141

808

M45

ICD-10 Finland

Ankylosing spondylitis

2.2

9.2

326

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

9.2

336

2369

K51.5

ICD-10 Finland

Left sided colitis

2.0

9.2

480

M54.2

ICD-10 Finland

Cervicalgia

1.5

9.2

297

2046

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.2

9.1

366

L28

ICPC

Limited function/disability (L)

1.3

9.1

599

4658

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

7.7

9.1

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

9.1

320

2240

B35.8

ICD-10 Finland

Other dermatophytoses

5.0

9.1

SFA00

NOMESCO Finland

Small restoration

1.4

9.1

504

3823

L64.9

ICD-10 Finland

Androgenic alopecia, unspecified

9.0

ZX120

NOMESCO Finland

Intravenous

1.5

9.0

294

2028

SPAT1229

SPAT

Assessment of need for aid

1.6

9.0

226

1474

F13

ICPC

Eye sensation abnormal

1.9

9.0

103

539

EB4VA, ,

NOMESCO Finland

1.3

9.0

655

5171

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

9.0

402

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

9.0

531

4066

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.4

8.9

236

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

8.9

114

618

D02

ICPC

Abdominal pain epigastric

1.6

8.9

224

1460

WX002

NOMESCO Finland

Sedation and analgesia

1.3

8.9

614

4807

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

8.9

838

6841

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

8.9

288

1982

G03DB01

ATC

dydrogesterone; oral

1.4

8.9

484

3657

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.9

1082

9111

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

8.9

573

4443

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.6

8.9

195

L28.1

ICD-10 Finland

Prurigo nodularis

3.3

8.9

102

L30

ICD-10 Finland

Other dermatitis

2.0

8.9

465

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

8.9

293

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.3

8.9

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

8.8

508

3872

L04AB01

ATC

etanercept; parenteral

2.3

8.8

287

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

8.8

287

M01AH01

ATC

celecoxib; oral

1.3

8.8

592

4617

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.0

8.8

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.0

8.8

481

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

8.8

302

2106

D09AB01

ATC

zinc bandage without supplements; topical

2.3

8.7

282

N04BC05

ATC

pramipexole; oral

1.5

8.7

246

1646

A92

ICPC

Allergy/allergic reaction NOS

1.9

8.7

112

609

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

4.1

8.7

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

8.7

217

1413

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

8.7

140

815

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

8.7

296

SPAT1009

SPAT

Measurement of intraocular pressure

2.6

8.7

186

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

8.6

251

1690

C02AC05

ATC

moxonidine; oral

1.8

8.6

135

779

H29

ICPC

Ear symptom/complaint other

1.4

8.6

407

3005

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.6

808

6592

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.0

8.6

429

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

8.6

947

7878

S91

ICPC

Psoriasis

3.0

8.6

125

D07AB01

ATC

clobetasone; topical

1.9

8.6

107

576

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

8.6

187

1180

R19.4

ICD-10 Finland

Change in bowel habit

1.9

8.5

107

577

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

6.9

8.5

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

8.5

354

2556

UDM02

NOMESCO Finland

Sinoscopy

2.1

8.5

377

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.5

462

3491

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

3.0

8.5

126

S01AD03

ATC

aciclovir; ophthalmic

1.8

8.5

116

644

K03.00

ICD-10 Finland

Approximal wear

1.5

8.4

274

1888

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

3.7

8.4

P06

ICPC

Sleep disturbance

1.4

8.4

459

3469

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

8.4

413

3069

L04AC05

ATC

ustekinumab; parenteral

3.9

8.4

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.7

8.4

160

S76

ICPC

Skin infection other

1.6

8.4

173

1077

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

8.4

121

683

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

8.3

164

1008

L43.3

ICD-10 Finland

Subacute (active) lichen planus

6.7

8.3

K51.8

ICD-10 Finland

Other ulcerative colitis

2.4

8.3

232

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

8.3

190

ZXA10

NOMESCO Finland

Bilateral

1.3

8.3

572

4479

N06AX16

ATC

venlafaxine; oral

1.3

8.3

514

3963

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

8.3

175

1096

SAA04

NOMESCO Finland

Special examination of mouth

1.7

8.3

163

1003

R49.01

ICD-10 Finland

Functional dysphonia

1.8

8.3

112

620

K90.0

ICD-10 Finland

Coeliac disease

1.9

8.2

100

534

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

8.2

106

577

ZXC20

NOMESCO Finland

Use of chemical agents

2.3

8.2

258

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.7

8.2

162

C08CA13

ATC

lercanidipine; oral

1.4

8.2

440

3317

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

8.2

427

3204

N05CF02

ATC

zolpidem; oral

1.3

8.2

607

4800

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

8.1

112

623

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

8.1

377

2776

WZC30, ,

SPAT

1.5

8.1

289

2029

L01BB02

ATC

mercaptopurine; oral

2.6

8.1

169

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

8.1

258

1772

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.0

8.1

460

H10

ICD-10 Finland

Conjunctivitis

1.5

8.1

264

1822

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

8.1

338

L40.4

ICD-10 Finland

Guttate psoriasis

3.8

8.1

F16

ICPC

Eyelid symptom/complaint

1.6

8.0

182

1159

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.9

8.0

532

R29

ICPC

Respiratory symptom/complaint other

1.5

8.0

233

1570

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

8.0

252

1726

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

8.0

525

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.4

8.0

218

G01AF05

ATC

econazole; vaginal

1.4

8.0

295

2086

N05CF01

ATC

zopiclone; oral

1.2

7.9

1055

8959

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

7.9

327

2361

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

7.8

393

2930

SPAT1360

SPAT

Extensive global examination

1.5

7.8

206

1358

D86.3

ICD-10 Finland

Sarcoidosis of skin

6.1

7.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.8

2028

18393

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.0

7.8

383

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

8.4

7.8

H01

ICPC

Ear pain/earache

1.4

7.8

406

3048

B35.3

ICD-10 Finland

Tinea pedis

1.6

7.8

154

950

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.3

7.8

246

M02AA07

ATC

piroxicam; topical

1.2

7.7

1187

10224

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

7.7

211

1403

SPAT1053

SPAT

Memory test

1.4

7.7

351

2575

D06BB04

ATC

podophyllotoxin; topical

1.6

7.7

164

1029

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

7.7

326

2362

K08.80

ICD-10 Finland

Toothache NOS

1.4

7.7

327

2371

L04AA32

ATC

apremilast; oral

6.4

7.7

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

3.9

7.7

S15

ICPC

Foreign body in skin

1.5

7.7

213

1421

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

2.9

7.7

117

A05

ICPC

Feeling ill

1.6

7.7

189

1228

L50.0

ICD-10 Finland

Allergic urticaria

1.9

7.7

504

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

7.7

1242

10755

A08

ICPC

Swelling

1.6

7.7

184

1189

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

3.2

7.7

R03AC13

ATC

formoterol; inhalant

1.6

7.6

162

1016

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

7.6

390

2917

L72.0

ICD-10 Finland

Epidermal cyst

2.9

7.6

123

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

4.0

7.6

ZQZ00

NOMESCO Finland

Treatment of several skin areas

4.0

7.6

K07

ICPC

Swollen ankles/oedema

1.7

7.6

139

840

B02.9

ICD-10 Finland

Zoster without complication

1.5

7.6

223

1507

M01CB01

ATC

sodium aurothiomalate; parenteral

2.4

7.6

199

D06BB03

ATC

aciclovir; topical

1.6

7.6

157

980

C05AA08

ATC

fluocortolone; rectal, topical

1.3

7.5

433

3300

R03BC03

ATC

nedocromil; inhalant

1.5

7.5

218

1469

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

7.5

322

2339

A11CC03

ATC

alfacalcidol; systemic

2.1

7.5

348

S02

ICPC

Pruritus

1.8

7.5

116

669

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

7.5

284

2018

L18

ICPC

Muscle pain

1.7

7.5

142

866

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

4.2

7.5

N39.3

ICD-10 Finland

Stress incontinence

1.5

7.5

267

1877

C08CA01

ATC

amlodipine; oral

1.2

7.4

1207

10450

H02AB09

ATC

hydrocortisone; systemic

1.9

7.4

425

3005

Kela drug reimbursment

Tofacitinib

4.4

7.4

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

4.4

7.4

J20

ICD-10 Finland

Acute bronchitis

1.4

7.4

352

2602

XQ801

NOMESCO Finland

Intracutantest

3.1

7.4

A07EA02

ATC

hydrocortisone; rectal

2.0

7.4

350

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.4

264

1855

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

3.2

7.4

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

7.4

113

650

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

7.4

115

665

R06AX18

ATC

acrivastine; oral

1.8

7.4

533

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

7.4

196

1297

TQW40, ,

SPAT

1.4

7.3

338

2485

N05BA01

ATC

diazepam; systemic, rectal

1.4

7.3

401

3032

L68.0

ICD-10 Finland

Hirsutism

8.4

7.3

SPAT1240

SPAT

Therapeutic discussion

1.4

7.3

342

2522

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

+∞

7.3

L01XX35

ATC

anagrelide; oral

9.4

7.3

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.7

7.3

115

668

ZX108

NOMESCO Finland

Inhalation

3.2

7.2

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

7.2

157

991

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

7.2

312

2269

T78.3

ICD-10 Finland

Angioneurotic oedema

2.3

7.2

216

K05.08

ICD-10 Finland

Another acute gingivitis

1.8

7.2

110

632

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.7

7.2

144

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.9

7.2

430

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.7

7.2

E000008, ,

ATC

7.3

7.2

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.2

7.2

242

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

7.2

375

M01AH02

ATC

rofecoxib; oral

1.4

7.1

376

2827

U02

ICPC

Urinary frequency/urgency

1.3

7.1

517

4073

N06AA09

ATC

amitriptyline; systemic

1.4

7.1

297

2147

H02.1

ICD-10 Finland

Ectropion of eyelid

3.1

7.1

M35.1

ICD-10 Finland

Other overlap syndromes

3.4

7.1

R5110, ,

SPAT

1.4

7.1

275

1962

A06AD11

ATC

lactulose; oral

1.3

7.1

404

3074

H02.3

ICD-10 Finland

Blepharochalasis

1.5

7.1

208

1406

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

7.1

216

1472

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.0

7.1

101

K11.2

ICD-10 Finland

Sialoadenitis

1.7

7.1

112

651

TGC00

NOMESCO Finland

Bronchial lavation

2.0

7.0

391

M02AA10

ATC

ketoprofen; topical

1.3

7.0

519

4097

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

7.0

350

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.1

7.0

283

WX723

NOMESCO Finland

CPAP therapy

1.6

7.0

141

873

L23

ICD-10 Finland

Allergic contact dermatitis

3.0

7.0

TEA00

NOMESCO Finland

Biopsy of lip

2.6

7.0

146

SPAT1097

SPAT

Recording of ECG

1.3

7.0

420

3219

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

7.0

534

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.5

7.0

179

1174

ZZR00

NOMESCO Finland

Flap of skin

2.1

7.0

290

S01KA02

ATC

hypromellose; ophthalmic

2.1

7.0

277

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.0

7.0

351

D01

ICPC

Abdominal pain/cramps general

1.3

7.0

425

3267

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

7.0

120

714

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

4.4

7.0

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

3.0

7.0

102

JG1JB

NOMESCO Finland

Defekography with X-ray

2.8

6.9

124

D19

ICPC

Teeth/gum symptom/complaint

1.2

6.9

1108

9565

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

3.7

6.9

L04AA13

ATC

[U] leflunomide

1.9

6.9

465

S12

ICPC

Insect bite/sting

1.4

6.9

280

2016

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.9

266

1898

N06AX26

ATC

vortioxetine; oral

1.4

6.8

253

1790

K59.0

ICD-10 Finland

Constipation

1.6

6.8

164

1061

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

2.7

6.8

131

L04AA29

ATC

[U] tofacitinib

4.1

6.8

R60.1

ICD-10 Finland

Generalized oedema

2.9

6.8

109

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.1

6.8

301

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

6.7

161

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.6

6.7

163

1057

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

6.7

748

6212

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

6.7

433

3355

S82

ICPC

Naevus/mole

1.3

6.7

483

3800

HMAK, ,

NOMESCO Finland

1.4

6.7

375

2846

R07.0

ICD-10 Finland

Pain in throat

1.4

6.7

241

1697

N48.1

ICD-10 Finland

Balanoposthitis

2.1

6.7

309

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

6.7

512

4063

A03FA02

ATC

cisapride; oral, rectal

1.5

6.7

209

1433

A12AA04

ATC

calcium carbonate; oral

2.3

6.6

199

S01BA01

ATC

dexamethasone; ophthalmic

1.7

6.6

106

618

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

6.6

343

2571

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

6.6

384

2929

L04AC18

ATC

risankizumab; parenteral

6.4

6.6

L53.8

ICD-10 Finland

Other specified erythematous conditions

4.0

6.6

QBA10

NOMESCO Finland

Incision of skin of trunk

2.6

6.6

139

S01GX04

ATC

nedocromil; ophthalmic

2.1

6.6

297

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

5.5

6.6

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

6.6

121

733

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

6.6

112

665

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

3.5

6.6

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

6.5

180

1201

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

6.5

166

1089

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

6.5

122

743

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.7

6.5

107

629

SBA00

NOMESCO Finland

Microbiological examinations

1.8

6.5

474

K58

ICD-10 Finland

Irritable bowel syndrome

1.8

6.4

505

L13.0

ICD-10 Finland

Dermatitis herpetiformis

3.9

6.4

L50.1

ICD-10 Finland

Idiopathic urticaria

2.8

6.4

107

L13.9

ICD-10 Finland

Bullous disorder, unspecified

3.4

6.4

D01AC02

ATC

miconazole; topical

1.5

6.4

214

1486

M10

ICD-10 Finland

Gout

1.7

6.4

112

670

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

6.4

236

1670

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.0

6.4

301

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

6.4

1001

8616

K29

ICPC

Cardiovascular sympt/complt other

1.7

6.4

121

740

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.7

6.4

A05AA02

ATC

ursodeoxycholic acid; oral

2.0

6.3

295

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

6.3

492

3910

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

6.3

233

1648

N01

ICPC

Headache

1.3

6.3

374

2862

A01

ICPC

Pain general/multiple sites

1.4

6.3

339

2556

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

2.3

6.3

185

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

2.9

6.3

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

6.3

303

2246

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

6.3

179

1204

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

6.3

136

860

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.3

331

2490

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.3

865

7348

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

6.3

155

1011

L29.2

ICD-10 Finland

Pruritus vulvae

2.0

6.3

331

N03AE01

ATC

clonazepam; systemic

1.5

6.2

176

1181

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.2

605

4944

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

6.2

330

2484

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.2

594

4844

R00.2

ICD-10 Finland

Palpitations

1.4

6.2

272

1985

D01AA02

ATC

natamycin; topical

2.0

6.2

339

R12

ICD-10 Finland

Heartburn

1.4

6.2

282

2071

S88

ICPC

Dermatitis contact/allergic

1.9

6.2

353

M15

ICD-10 Finland

Polyarthrosis

1.5

6.2

164

1086

H15.0

ICD-10 Finland

Scleritis

4.0

6.2

H16.8

ICD-10 Finland

Other keratitis

4.0

6.2

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.1

6.2

285

B00.11

ICD-10 Finland

Herpes simplex labialis

2.0

6.2

326

S80.0

ICD-10 Finland

Contusion of knee

1.4

6.2

259

1877

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.9

6.1

347

395

Kela drug reimbursment

Dupilumab

5.3

6.1

H00

ICD-10 Finland

Hordeolum and chalazion

2.4

6.1

175

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

6.1

101

595

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

2.6

6.1

127

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.0

6.1

286

XCK00

NOMESCO Finland

Perimetry

1.5

6.1

174

1171

H92.0

ICD-10 Finland

Otalgia

1.4

6.1

217

1526

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.1

828

7020

C03BA11

ATC

indapamide; oral

1.9

6.1

419

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

4.1

6.1

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.1

646

5334

M19.8

ICD-10 Finland

Other specified arthrosis

1.6

6.1

136

867

G04CA02

ATC

tamsulosin; oral

1.3

6.0

513

4124

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

6.0

209

1462

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.4

6.0

164

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

6.7

6.0

D94

ICPC

Chronic enteritis/ulcerative colitis

2.7

6.0

111

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

2.7

6.0

111

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

6.0

120

744

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

1158

5620

2.48

135.46

1.6

1.4

607.54

562.37

titre

0.30

297

1231

(40768443) Skin Pathology biopsy report

491

1593

3.37

121.34

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

489

1666

3.20

111.13

2.5

1.9

15.26

7.26

iu/ml

0.43

141

393

(3015171) Extractable nuclear Ab [Units/volume] in Serum

452

1598

3.06

95.86

1.4

1.3

1.46

1.24

u/ml

0.12

118

(3001604) Monocytes [#/volume] in Blood

2549

18879

1.94

86.55

9.1

6.3

0.55

0.57

e9/l

3.77

2314

16252

(3006315) Basophils [#/volume] in Blood

2554

18929

1.94

86.53

9.1

6.3

0.04

e9/l

0.05

2317

16282

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

370

1236

3.19

86.17

2.4

1.8

1.17

1.20

g/l

1.07

355

1178

(3013115) Eosinophils [#/volume] in Blood

2607

19555

1.93

83.97

9.3

6.5

0.18

0.19

e9/l

2.18

2386

17120

(3019198) Lymphocytes [#/volume] in Blood

2582

19308

1.93

83.91

9.1

6.4

1.86

1.93

e9/l

1.54

2371

17048

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

358

1191

3.20

83.90

2.4

1.9

0.22

0.23

g/l

1.59

339

1133

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3321

27219

2.22

82.30

6.3

4.4

11.78

11.69

mm/h

0.15

3168

25666

(3005322) IgE [Units/volume] in Serum or Plasma

594

2637

2.47

80.17

1.4

1.3

187.63

186.83

u/ml

0.01

572

2458

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

298

950

3.31

74.73

1.4

1.3

4.20

3.05

u/ml

0.18

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

351

1263

2.95

71.49

1.5

1.3

25.20

40.36

u/ml

0.60

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

329

1169

2.97

68.47

1.5

1.3

11.07

5.95

u/ml

0.41

113

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

328

1174

2.95

67.35

1.5

1.3

9.22

7.87

u/ml

0.13

175

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3305

27777

2.03

65.38

10.5

8.3

77.04

77.93

u/l

0.58

3171

26470

(3013650) Neutrophils [#/volume] in Blood by Automated count

2673

21179

1.77

61.55

11.7

9.7

3.93

4.03

e9/l

1.64

2453

18391

(3007853) Bacteria identified in Skin by Aerobe culture

759

4177

2.01

58.75

2.0

1.7

—

(3019069) Monocytes/Leukocytes in Blood

2273

17364

1.70

58.11

9.5

6.6

8.68

8.70

0.15

2178

16306

(3006504) Eosinophils/Leukocytes in Blood

2267

17327

1.70

57.65

9.4

6.5

2.78

2.83

0.40

2169

16252

(3048689) Calprotectin [Mass/mass] in Stool

870

5067

1.91

56.83

3.0

2.4

126.09

124.78

ug/g

0.04

686

4059

(3018010) Neutrophils/Leukocytes in Blood

2280

17495

1.69

56.74

9.1

6.4

57.14

57.00

0.24

2218

16725

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1193

7687

1.78

56.14

1.5

1.3

34.64

29.43

iu/ml

0.48

348

2383

(3022096) Basophils/Leukocytes in Blood

2257

17329

1.68

55.51

9.5

6.6

0.73

0.69

2.44

2157

16238

(3002030) Lymphocytes/Leukocytes in Blood

2302

17791

1.68

54.99

9.4

6.5

28.27

28.28

0.01

2218

16890

(3029937) Albumin [Presence] in Urine by Test strip

1513

10611

1.68

51.40

5.2

4.0

0.00

estimate

2.37

506

3788

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1104

7167

1.74

49.49

1.4

1.3

7.45

10.34

u/ml

1.02

456

2870

(3009261) Glucose [Presence] in Urine by Test strip

2466

19736

1.64

48.41

5.0

3.8

0.01

0.10

estimate

0.59

518

3885

(3021601) Nitrite [Presence] in Urine by Test strip

2432

19405

1.63

48.26

5.0

3.8

0.00

estimate

0.64

549

4015

(3026493) Urate [Moles/volume] in Serum or Plasma

1365

9442

1.67

48.11

3.2

2.6

334.59

329.67

umol/l

1.03

1203

8430

(40760892) CBC W Ordered Manual Differential panel - Blood

1268

8607

1.69

48.00

6.4

4.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1333

9171

1.68

47.93

1.4

1.3

1.56

1.71

u/ml

0.15

380

2554

(3035350) Ketones [Presence] in Urine by Test strip

2447

19611

1.63

47.17

5.0

3.8

2.66

3.84

estimate

0.16

546

4110

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2213

17323

1.61

46.88

3.0

2.5

77.82

77.53

nmol/l

0.19

2065

15895

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

254

963

2.75

46.56

1.4

1.2

46.56

42.66

u/ml

0.15

101

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

180

565

3.29

46.07

1.3

1.1

15.00

10.44

u/ml

0.20

(3037467) Urinalysis macro (dipstick) panel - Urine

2944

24833

1.68

45.18

5.8

4.5

0.61

2.83

—

(3000494) Fungus identified in Specimen by Culture

751

4485

1.83

44.09

1.7

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1577

11577

1.59

42.31

3.1

2.6

57.11

66.77

u/l

0.77

1460

10756

(3015736) pH of Urine

2011

15629

1.57

42.04

4.4

3.4

6.28

6.22

1.46

1131

8865

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2255

18056

1.56

40.80

8.3

7.1

1.21

mmol/l

0.15

1974

15652

(3005719) IgG [Mass/volume] in Serum or Plasma

538

2957

1.94

40.63

3.3

3.0

10.88

10.62

g/l

0.66

502

2747

(3007164) IgA [Mass/volume] in Serum or Plasma

1156

7952

1.63

40.11

1.6

1.5

2.52

2.36

g/l

1.77

766

5048

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3311

29135

1.75

39.99

5.7

4.6

14.76

14.66

pmol/l

1.62

3099

27097

(3024561) Albumin [Mass/volume] in Serum or Plasma

2052

16137

1.55

39.87

6.3

5.0

36.22

35.94

g/l

1.58

1926

15198

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2357

19193

1.55

38.50

6.8

6.6

11.00

10.97

umol/l

0.04

2241

18342

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1898

14744

1.54

38.48

4.8

3.7

0.04

0.06

estimate

0.25

449

3295

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3826

35429

2.43

38.24

19.7

15.2

20.19

22.75

mg/l

5.25

3276

29071

(3039162) Centromere protein B Ab [Units/volume] in Serum

151

503

3.08

35.00

1.4

1.3

66.76

60.26

u/ml

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2022

16156

1.50

34.42

7.4

6.4

1.21

mmol/l

0.02

1891

15002

(3028026) IgM [Mass/volume] in Serum or Plasma

429

2316

1.95

33.85

1.9

1.31

1.36

g/l

0.14

394

2145

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3668

33676

1.94

33.43

6.9

5.6

1.87

mu/l

0.01

3472

31566

(3031040) Bacteria [#/volume] in Urine by Automated count

2779

23808

1.53

33.19

5.5

4.6

2264.62

1916.02

e6/l

0.11

305

(40768804) Tissue Pathology biopsy report

1925

15359

1.48

32.16

2.5

2.1

—

(3004616) Nuclear Ab [Presence] in Serum

145

503

2.95

31.31

1.5

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

324

1628

2.08

31.20

2.0

40.49

39.77

u/l

0.26

295

1472

(3019150) Specific gravity of Urine by Refractometry

1172

8547

1.52

29.83

5.2

3.9

1.02

1.37

kg/l

0.81

814

5679

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1453

11120

1.48

29.04

2.5

2.2

149.10

195.97

u/l

2.23

1356

10567

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

122

402

3.10

28.84

1.3

1.2

66.83

33.08

u/ml

0.64

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

223

1004

2.29

28.26

2.2

2.1

11.20

11.66

mg/l

0.34

212

932

(3009445) Proteinase 3 Ab [Units/volume] in Serum

297

1504

2.05

27.95

2.2

1.6

19.84

18.34

iu/ml

0.06

(3022145) Colonoscopy Study observation

653

4213

1.66

27.91

1.4

—

(3021589) Normoblasts [#/volume] in Blood

2004

16414

1.44

27.48

14.8

11.1

0.00

e9/l

0.68

1721

13342

(3038026) Centromere Ab [Units/volume] in Serum

100

301

3.38

27.42

1.3

1.2

48.50

58.19

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3686

34241

1.85

27.37

5.7

5.0

5.83

5.85

mmol/l

0.52

3474

31838

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1271

9571

1.48

27.13

2.6

2.3

2.92

2.75

mg/l

1.20

1126

8338

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1665

13211

1.44

26.97

3.9

3.6

61.15

90.37

ng/l

0.24

1095

8583

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2219

18577

1.43

26.61

3.8

3.1

121.84

109.16

ug/l

0.99

2094

17502

(3022948) Iron [Moles/volume] in Serum or Plasma

883

6199

1.54

26.26

3.0

2.5

13.57

13.39

umol/l

0.32

831

5799

(3036481) Cortisol [Moles/volume] in Serum or Plasma

582

3710

1.66

25.93

2.4

2.2

354.53

376.06

nmol/l

1.38

535

3457

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1032

7519

1.50

25.68

1.8

1.7

46339118.35

40075752.53

pmol/l

0.10

874

6373

(3023103) Potassium [Moles/volume] in Serum or Plasma

3819

35998

2.06

25.57

21.6

17.5

3.95

mmol/l

0.11

3763

35277

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

258

1286

2.07

25.31

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

717

4838

1.59

25.30

3.2

4.30

4.40

e9/l

0.17

637

4243

(3019550) Sodium [Moles/volume] in Serum or Plasma

3812

35925

2.03

25.27

21.4

17.3

139.54

139.71

mmol/l

4.16

3763

35272

(3002179) Metamyelocytes/Leukocytes in Blood

511

3178

1.70

24.94

5.7

4.4

0.77

0.69

0.25

152

919

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

249

1237

2.08

24.65

1.6

1.5

1.24

6.06

iu/ml

0.39

210

(3021960) Folate [Moles/volume] in Serum or Plasma

1320

10159

1.44

24.60

1.8

1.7

20.24

20.54

nmol/l

0.33

1150

8690

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3923

37435

2.51

24.43

17.0

11.9

25.71

25.50

u/l

0.38

3855

36514

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3769

35436

1.91

24.37

6.1

5.0

4.66

4.73

mmol/l

3.88

3593

33476

(3025159) Blasts/Leukocytes in Blood

519

3261

1.68

24.34

6.2

4.7

0.26

0.33

0.19

133

793

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

118

424

2.84

23.96

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

807

5662

1.53

23.78

1.8

1.7

1190.13

1168.32

nmol/l

0.27

621

4362

(3004789) Transferrin [Mass/volume] in Serum or Plasma

815

5735

1.53

23.67

3.0

2.5

2.36

2.35

g/l

0.35

757

5325

(3017181) Myelocytes/Leukocytes in Blood

525

3336

1.66

23.54

5.9

4.5

0.91

0.88

0.06

148

969

(3021440) Promyelocytes/Leukocytes in Blood

507

3197

1.67

23.41

6.0

4.6

0.12

0.11

0.18

131

831

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1930

15981

1.40

23.36

2.3

2.1

98.14

97.35

pmol/l

0.30

1085

8351

(3018418) pH of Serum or Plasma

1401

10978

1.42

23.35

5.2

4.2

7.40

0.33

1006

7860

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3599

33469

1.67

23.12

6.9

6.0

38.33

38.79

mmol/mol

3.12

3400

31579

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3796

35865

1.92

22.80

6.5

5.6

2.72

2.77

mmol/l

3.41

3593

33740

(3013826) Glucose [Moles/volume] in Serum or Plasma

2433

21026

1.39

22.36

5.7

4.9

6.46

6.61

mmol/l

3.60

2316

19872

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1277

9913

1.42

22.16

3.2

3.1

1100.40

1124.05

ng/l

0.07

1079

8491

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3600

33579

1.65

21.64

5.1

4.2

1.29

1.27

mmol/l

1.03

3400

31269

(3032080) INR in Blood by Coagulation assay

1906

15875

1.38

21.63

14.6

13.5

1.22

1.21

inr

0.08

1608

13174

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

442

2748

1.68

21.45

1.6

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

590

3943

1.58

21.40

4.8

4.5

247.32

244.41

u/l

0.16

560

3741

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

747

5264

1.51

21.31

3.1

2.6

23.20

23.03

0.14

700

4899

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3740

35267

1.79

21.27

5.7

4.9

1.49

1.50

mmol/l

1.21

3534

33124

(3000850) Epithelial cells [#/volume] in Urine

1065

8050

1.44

21.25

3.4

2.7

6.29

6.30

e6/l

0.00

992

7332

(3017143) Hepatitis C virus Ab [Presence] in Serum

641

4390

1.55

20.83

1.8

1.6

—

(3044889) 12 lead EKG panel

2814

25066

1.40

20.66

4.5

3.8

0.27

2104.92

0.49

(3041096) Erythrocytes [Presence] in Urine by Automated

1341

10629

1.39

20.18

3.8

3.2

0.13

0.12

estimate

0.03

427

3200

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1867

15640

1.36

19.76

2.3

1.9

1.35

mmol/l

0.03

1596

13313

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

203

3.44

19.69

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

415

2613

1.66

19.11

2.0

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

144

638

2.30

18.99

1.4

1.3

295.42

403.64

titre

0.19

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3916

37641

2.20

18.75

25.2

19.3

75.92

74.02

umol/l

3.03

3889

37257

(3020630) Protein [Mass/volume] in Serum or Plasma

448

2890

1.62

18.71

2.5

2.8

67.18

66.60

g/l

0.96

412

2668

(36660697) Celiac disease serology panel - Serum

480

3161

1.59

18.38

1.2

—

(40768797) Stomach Pathology biopsy report

736

5315

1.47

18.33

1.3

1.2

—

(3033099) Centromere Ab [Titer] in Serum

4.86

18.23

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1571

12925

1.35

18.20

3.5

2.35

2.36

mmol/l

1.80

1430

11855

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1088

8447

1.39

18.12

1.8

0.91

1.13

mg/l

3.02

819

6564

(3000963) Hemoglobin [Mass/volume] in Blood

3984

38622

2.88

18.04

30.6

23.3

134.75

134.46

g/l

0.71

3957

38286

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

452

2949

1.60

17.99

1.2

98.46

148.42

u/ml

2.51

203

1124

(3007461) Platelets [#/volume] in Blood

3982

38604

2.82

17.82

30.5

23.2

256.96

256.70

e9/l

0.09

3940

37930

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3982

38609

2.82

17.72

30.3

23.1

91.39

91.02

5.59

3956

38270

(3013139) Helicobacter pylori Ag [Presence] in Stool

424

2734

1.62

17.71

1.2

1.3

—

(3035941) MCH [Entitic mass]

3982

38610

2.81

17.70

30.3

23.0

30.39

30.28

3.98

3956

38270

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3982

38613

2.81

17.64

30.9

23.5

41.50

40.77

0.28

3957

38255

(3026361) Erythrocytes [#/volume] in Blood

3982

38614

2.81

17.62

30.4

23.1

4.47

e12/l

0.23

3928

37836

(3010813) Leukocytes [#/volume] in Blood

3982

38616

2.80

17.58

30.5

23.2

6.66

e9/l

0.00

3930

37836

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3635

34270

1.59

17.53

18.1

14.5

82.13

82.78

ml/min/173m2

1.18

3421

31705

(3026389) Candida sp identified in Specimen by Organism specific culture

123

533

2.35

17.10

1.4

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1542

12745

1.34

16.98

3.9

3.2

32.63

32.90

u/l

0.05

1459

12084

(3003458) Phosphate [Moles/volume] in Serum or Plasma

650

4651

1.47

16.84

7.9

5.8

1.04

mmol/l

0.04

617

4324

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

225

3.10

16.73

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

205

3.21

16.66

1.2

1.3

72.00

68.13

titre

—

(3018095) Leukocytes [#/volume] in Urine

1624

13552

1.33

16.64

5.1

3.8

79.29

94.78

e6/l

0.35

1217

9415

(3042936) Bacteria identified in Isolate by Culture

696

5068

1.45

16.43

2.1

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

398

2.52

16.23

1.2

—

(3045414) Leukocytes [Presence] in Urine

514

3531

1.52

16.21

2.2

2.1

0.01

estimate

0.21

111

745

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

952

7345

1.39

16.16

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

337

2098

1.66

16.16

1.4

1.2

—

(3045424) Erythrocytes [Presence] in Urine

297

1793

1.71

15.98

2.3

2.2

0.00

0.44

estimate

0.51

584

(3011397) Hemoglobin [Presence] in Urine by Test strip

1125

8945

1.36

15.75

5.3

3.7

0.17

0.16

—

(3002582) Erythrocytes [#/volume] in Urine

1414

11638

1.33

15.68

4.2

3.3

63.35

86.87

e6/l

0.28

1131

8833

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2787

25265

1.33

15.12

3.9

3.2

50.21

44.72

u/l

1.58

2621

23919

(3008898) HLA-B27 [Presence]

252

1480

1.75

14.97

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

260

1545

1.73

14.82

2.8

2.2

4571.91

5825.59

u/l

0.27

627

(3024980) IgG subclass 4 [Mass/volume] in Serum

137

661

2.11

14.72

1.4

1.6

0.63

0.74

g/l

0.59

114

512

(3035933) Granulocytes/Leukocytes in Blood

159

814

1.99

14.55

4.2

3.2

55.29

57.93

1.92

159

814

(3007566) Smooth muscle Ab [Titer] in Serum

198

1095

1.85

14.38

1.2

57.37

157.42

titre

1.14

(3034770) Mitochondria Ab [Titer] in Serum

198

1095

1.85

14.38

1.2

1177.14

1011.79

titre

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

356

2.50

14.28

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

112

506

2.25

14.19

1.1

1.48

1.50

g/l

0.24

100

460

(3023520) Reticulocytes [#/volume] in Blood

432

2948

1.52

13.97

2.7

69.28

70.22

e9/l

0.22

307

2163

(3013512) EKG study

1446

12082

1.31

13.97

3.6

3.4

0.33

0.77

—

(3003327) Ova and parasites identified in Stool by Light microscopy

235

1381

1.74

13.94

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

424

2887

1.52

13.86

2.8

2.5

0.26

0.43

e6/l

1.73

393

2740

(40759836) Histone Ab [Presence] in Serum by Immunoblot

345

2.50

13.71

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

300

1893

1.63

13.62

1.2

1.1

20.71

127.39

titre

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

745

2.00

13.50

8.9

5.6

242.46

516.07

iu/ml

0.80

107

(40758558) Short blood count panel - Blood

1358

11298

1.30

13.40

7.6

6.3

—

(4062490) Immunoglobulin typing, IgG

404

2.36

13.39

1.3

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

539

3877

1.45

13.39

2.8

2.6

1.78

1.79

0.10

490

3463

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

323

2.51

13.07

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

341

2.46

13.07

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

341

2.46

13.07

1.2

—

(44813793) Dust mix specific IgE antibody measurement

282

2.62

13.05

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

411

2817

1.51

13.00

4.8

3.7

89.94

86.36

ng/l

0.34

354

2441

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

238

2.76

12.90

1.6

1.5

20.69

21.47

u/ml

0.04

(3023368) Bacteria identified in Blood by Culture

1147

9398

1.31

12.49

4.4

4.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

411

2.29

12.46

1.4

3.40

2.92

g/l

1.15

295

(3024139) IgG subclass 3 [Mass/volume] in Serum

411

2.29

12.46

1.4

0.55

0.41

g/l

0.38

295

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

541

3948

1.43

12.38

7.9

6.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

142

3.27

12.29

1.3

1.2

0.29

g/l

0.22

116

(3030467) Casts [#/volume] in Urine by Automated count

1215

10050

1.30

12.28

4.1

3.2

0.33

0.38

e6/l

0.43

937

7329

(3026008) Bacteria identified in Urine by Culture

1322

11056

1.29

12.28

3.4

3.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

788

6130

1.35

12.27

1.8

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

330

2.42

12.03

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

412

2.26

11.96

1.3

1.4

6.48

6.90

g/l

0.54

294

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

120

3.44

11.91

3.3

3.1

7.95

8.62

mg/l

0.28

(3018333) Ribosomal P Ab [Presence] in Serum

314

2.45

11.86

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

777

6062

1.35

11.83

3.8

3.4

0.81

0.82

mmol/l

1.00

726

5724

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

397

2763

1.48

11.63

2.5

2.4

13.59

20.39

au/ml

2.33

322

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

412

2.24

11.54

1.1

—

2.89

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

418

2948

1.47

11.45

2.8

2.7

65.64

68.36

ml/min/173m2

0.78

195

1222

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.83

11.42

1.9

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

112

3.42

10.95

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

112

3.42

10.95

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

112

3.42

10.95

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

112

3.42

10.95

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

137

738

1.89

10.87

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2590

23685

1.26

10.76

3.2

3.1

—

(3012516) Albumin [Mass/volume] in Urine

1346

11425

1.27

10.75

3.8

3.4

52.79

43.56

mg/l

0.53

804

7132

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

156

881

1.80

10.66

1.1

2.45

2.12

u/ml

0.11

449

(3009508) Creatinine [Moles/volume] in Urine

1435

12285

1.26

10.63

3.8

3.4

7.26

7.41

mmol/l

0.68

1239

10481

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

365

2548

1.48

10.52

1.3

56.23

50.53

au/ml

0.13

180

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

3.70

10.40

2.1

1.7

56.13

147.93

au/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

225

2.60

10.36

1.5

1.7

4.84

5.73

u/l

1.21

199

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

107

3.39

10.26

3.0

2.5

116.45

140.62

au/ml

—

(3010375) cycloSPORINE [Mass/volume] in Blood

143

3.03

10.21

20.8

26.4

108.03

111.95

ug/l

0.14

115

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

204

2.67

10.17

2.8

36.88

43.20

1.34

114

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

164

955

1.75

10.11

1.8

1.5

9.12

15.48

iu/ml

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

189

1148

1.68

10.00

1.3

1.4

326.92

288.89

ug/g

1.28

101

654

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3197

30107

1.29

9.81

23.4

18.5

13.62

13.56

1.74

3173

29728

(46235355) HIV 1 and 2 tests - Meaningful Use set

882

7171

1.29

9.80

2.0

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

191

2.69

9.78

1.3

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

123

665

1.88

9.69

1.7

1.4

158.34

156.84

au/ml

0.04

190

(3021879) Hepatitis B virus core Ab [Presence] in Serum

409

2975

1.42

9.45

1.7

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

180

1101

1.66

9.30

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

190

1183

1.64

9.16

1.3

1.2

—

(3002256) Pathology report gross observation

638

5011

1.32

9.08

1.4

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1345

11585

1.24

9.08

4.6

4.1

11.94

7.90

mg/mmol

1.17

798

7101

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

730

5846

1.30

9.02

2.0

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

127

713

1.81

8.91

2.2

2.0

4.93

5.15

mmol/24h

0.33

118

629

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

127

714

1.80

8.87

1.3

1.2

306.59

264.52

u/ml

0.59

445

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

882

7268

1.27

8.69

2.9

2.44

2.45

mmol/l

0.75

790

6543

(3010726) Horse dander IgE Ab [Units/volume] in Serum

125

705

1.80

8.65

1.1

1.64

1.36

u/ml

0.22

325

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

369

2678

1.42

8.64

4.2

3.5

4.45

4.47

pmol/l

0.13

331

2427

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

104

3.19

8.62

1.8

1.6

8.71

8.75

ug/l

0.02

104

(3020779) Urea [Moles/volume] in Serum or Plasma

414

3066

1.39

8.61

10.8

7.4

9.85

9.37

mmol/l

0.71

398

2941

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

108

585

1.87

8.51

3.8

2.8

927.36

1489.67

u/ml

0.21

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

505

3868

1.35

8.50

2.2

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

267

1835

1.49

8.34

2.3

2.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

270

2.28

8.27

2.0

2.3

—

(3026782) Osmolality of Urine

827

6811

1.27

8.12

3.8

2.9

510.05

524.19

mosm/kgh2o

1.13

735

5985

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

168

1049

1.63

8.05

3.7

3.2

1.54

1.50

mg/l

0.22

157

965

(3011412) CD3 cells [#/volume] in Blood

352

2.09

8.03

2.3

2.5

1348.30

1231.17

e6/l

0.58

315

(3018677) aPTT in Platelet poor plasma by Coagulation assay

670

5383

1.29

8.01

2.1

29.28

29.44

0.29

646

5238

(3042733) HLA Ab [Presence] in Serum

3.15

7.94

7.2

5.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1356

1.55

7.89

2.2

2.4

2.83

2.90

g/l

0.46

193

1247

(3003888) Timothy IgE Ab [Units/volume] in Serum

131

770

1.72

7.89

1.1

4.31

4.57

u/ml

0.07

385

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

162

1012

1.63

7.76

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

234

2.33

7.71

2.2

2.6

536.22

549.03

e6/l

0.06

191

(42529406) Shigella sp [Presence] in Stool by Culture

163

1023

1.62

7.66

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

126

739

1.73

7.66

1.1

1.46

1.22

u/ml

0.17

305

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1441

1.52

7.60

2.2

2.4

3.76

3.69

g/l

0.26

201

1333

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1441

1.52

7.60

2.2

2.4

4.27

4.24

g/l

0.19

202

1330

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1442

1.52

7.57

2.2

2.4

7.22

7.36

g/l

0.64

202

1332

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

226

1532

1.50

7.57

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

161

1014

1.61

7.47

1.1

13.37

6.16

eliau/ml

0.32

125

(3014765) Yersinia sp identified in Stool by Organism specific culture

161

1015

1.61

7.44

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

129

769

1.70

7.41

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

3.05

7.30

1.8

2.5

0.17

0.13

e9/l

0.41

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

301

2176

1.41

7.22

3.8

3.6

5.01

5.15

kpa

3.11

286

2093

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

4.49

7.17

1.0

0.01

0.22

u/ml

0.61

(3037121) Protein [Mass/volume] in Urine

178

1163

1.55

7.08

4.0

3.3

291.99

395.06

mg/l

0.44

473

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

105

599

1.77

7.06

1.4

1.3

5.06

4.39

u/ml

0.14

266

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

175

1140

1.56

7.06

2.8

2.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

551

4392

1.29

6.95

1.7

1.42

1.43

0.03

473

3874

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

107

617

1.75

6.94

1.3

1.2

3.59

4.01

u/ml

0.06

225

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

240

2.22

6.87

2.4

2.8

215.56

220.87

e6/l

0.06

208

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.10

6.81

5.3

6.4

—

1971.00

—

(3011985) Renin [Units/volume] in Plasma

525

1.81

6.80

1.7

1.5

66.29

60.63

mu/l

0.11

475

(3014051) Protein [Presence] in Urine by Test strip

1229

10734

1.21

6.80

3.4

2.9

0.13

0.02

0.37

215

(3009343) pH of Capillary blood

290

2108

1.40

6.75

3.7

3.6

7.42

0.15

232

1756

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

217

1498

1.47

6.68

1.6

15.29

13.49

u/ml

0.18

373

(3009871) Measles virus Ab [Titer] in Serum

145

2.57

6.60

1.5

1.7

6400.00

3401.48

titre

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

857

7239

1.23

6.58

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

297

2178

1.39

6.57

2.5

2.3

12.17

12.73

nmol/l

0.55

270

1968

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

488

1.82

6.53

1.3

1.4

306.89

325.07

pmol/l

0.27

425

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

285

2080

1.40

6.49

1.1

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

220

1535

1.46

6.42

1.7

1.8

1.46

1.54

g/l

0.63

199

1331

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

536

4300

1.28

6.42

2.3

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

536

4305

1.28

6.36

2.0

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

335

2523

1.36

6.29

1.4

26.84

30.05

iu/l

0.98

289

2185

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

372

2848

1.34

6.27

4.4

3.8

1.22

1.23

mmol/l

0.83

311

2469

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

114

2.73

6.27

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

104

2.80

6.14

1.0

1.1

0.59

1.69

u/ml

0.63

(3020123) Porphyrins [Interpretation] in Serum or Plasma

7.67

6.11

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

455

1.82

6.10

1.4

1.6

406.63

363.89

mu/l

0.38

368

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

1228

1.50

6.10

2.2

2.4

10.32

10.11

g/l

0.25

166

1108

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

151

2.46

6.09

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

446

3518

1.30

6.08

2.5

2.2

0.21

g/l

0.12

410

3307

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

146

2.48

6.01

3.9

4.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

183

1253

1.48

5.90

2.4

2.5

0.63

0.89

g/l

0.52

163

1087

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.12

5.88

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

3.40

5.85

1.1

0.03

1.97

u/ml

0.59

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

542

4404

1.27

5.84

2.8

2.7

7.13

7.38

umol/l

0.13

473

3861

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

508

4097

1.27

5.82

2.0

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

119

2.62

5.79

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

265

2.05

5.78

1.2

—

(40768446) Kidney Pathology biopsy report

131

2.53

5.77

1.5

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

172

1171

1.49

5.72

3.1

3.6

33.66

63.54

mg/l

1.41

140

1008

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

181

1247

1.47

5.67

2.6

2.2

365.79

646.49

ug/l

0.82

161

1174

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

169

2.32

5.66

1.1

98.39

93.21

0.44

135

(3014148) Varicella zoster virus Ab [Titer] in Serum

549

1.71

5.63

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

254

1869

1.38

5.54

1.5

1.4

—

(3019225) pH of Specimen

421

3337

1.29

5.53

4.6

4.2

7.36

7.35

0.13

316

2380

(3034860) Kappa light chains.free [Mass/volume] in Serum

171

1171

1.48

5.53

3.1

3.6

41.42

53.50

mg/l

1.04

137

1009

(3042631) Mycobacterium sp identified in Specimen

440

1.79

5.53

2.9

2.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

332

2548

1.33

5.52

3.2

2.9

149.96

177.19

ng/l

0.82

300

2322

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

263

2.03

5.52

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

744

6298

1.22

5.52

3.6

2.8

0.91

1.19

e6/l

1.11

432

3292

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

104

637

1.65

5.49

1.4

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

313

1.93

5.43

1.5

1.4

22096.83

73034.53

e6/l

1.00

212

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

158

1070

1.50

5.41

1.8

2.4

0.00

0.02

g/l

2.09

146

968

(3019060) Gas panel - Arterial blood

269

2009

1.36

5.36

5.0

5.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

460

1.75

5.33

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

149

2.36

5.31

1.1

1.2

—

0.15

g/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

295

2242

1.34

5.25

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

319

1.89

5.16

1.1

109.12

109.67

pmol/l

0.03

319

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

436

1.76

5.12

2.1

1.8

704.00

1476.36

titre

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

321

1.88

5.07

1.3

2.69

0.89

u/ml

0.56

168

(3015076) Soybean IgE Ab [Units/volume] in Serum

239

2.02

4.99

1.1

1.0

0.22

1.80

u/ml

0.51

(3008152) Bicarbonate [Moles/volume] in Arterial blood

280

2130

1.34

4.97

7.2

7.0

24.38

24.42

mmol/l

0.07

265

2043

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

345

1.84

4.96

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

695

1.58

4.93

1.7

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

317

1.87

4.93

1.3

1.5

29.67

33.85

0.35

186

(3020876) Protein [Mass/time] in 24 hour Urine

419

1.76

4.92

2.3

2.4

1.73

1.28

g/24h

0.36

248

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.67

4.90

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

453

1.71

4.78

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

245

1840

1.35

4.74

3.5

1.06

1.84

mmol/l

2.51

169

1372

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

1035

1.47

4.73

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

485

1.68

4.72

1.9

2.0

5.56

5.33

umol/l

0.11

353

(3024522) Salmonella sp identified in Specimen by Organism specific culture

455

1.71

4.71

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

132

889

1.50

4.69

1.7

1.6

10427.97

11550.05

e6/l

0.13

100

618

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

150

1038

1.46

4.66

3.1

3.5

1.82

3.28

ratio

1.26

595

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

153

1064

1.46

4.64

2.6

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

239

1.98

4.63

1.1

1.05

ratio

0.16

192

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

342

2704

1.29

4.61

2.5

2.3

8.51

7.05

ug/l

0.24

298

2413

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.12

4.60

1.9

2.2

1.95

2.80

mg/l

0.62

(3021447) Carbon dioxide [Partial pressure] in Venous blood

417

3381

1.26

4.58

5.6

3.6

5.81

kpa

0.04

408

3293

(3025468) Yersinia sp identified in Specimen by Organism specific culture

429

1.71

4.56

1.4

—

(3012544) pH of Venous blood

421

3422

1.26

4.53

5.7

3.6

7.38

0.29

234

1903

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

639

1.58

4.52

1.1

5.91

3.37

u/ml

0.69

298

(1616796) Gas panel - Central venous blood

116

768

1.53

4.48

4.0

3.7

—

(4195642) Thrombophilia screening test

570

1.61

4.47

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

432

1.70

4.46

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

156

2.19

4.39

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

434

1.69

4.39

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

139

960

1.46

4.38

1.9

1.6

—

(3024471) HLA-A [Type]

2.56

4.38

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

147

1027

1.45

4.37

1.9

2.4

0.00

g/l

-0.00

129

907

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

203

2.03

4.37

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.65

4.36

2.8

2.2

—

(40761536) Microorganisms panel - Urine sediment

366

2940

1.27

4.35

4.7

3.9

—

(3037756) Immunofixation for Serum or Plasma

108

709

1.54

4.35

1.6

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

119

2.36

4.31

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

467

1.66

4.31

1.5

1.3

—

nmol/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

824

1.50

4.31

1.7

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

253

1.91

4.29

1.3

1.2

76.18

86.62

—

(3019832) Treponema pallidum Ab [Presence] in Serum

459

3792

1.24

4.27

1.8

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

149

1051

1.43

4.22

1.2

2.54

4.30

2.37

147

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

262

1.88

4.21

2.1

2.0

18.19

18.67

nmol/l

0.13

249

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

159

2.15

4.20

1.2

1.1

6.69

5.84

u/ml

—

(3024932) HLA-DR beta [Type]

2.54

4.12

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

126

865

1.47

4.12

1.2

1.3

3.74

3.71

mmol/l

0.12

118

823

(3045716) Anion gap in Serum or Plasma by calculation

367

1.73

4.10

2.8

3.3

9.82

10.64

mmol/l

1.09

362

(3016650) Hepatitis A virus Ab [Presence] in Serum

647

1.54

4.09

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

138

966

1.44

4.08

2.8

3.2

1.93

1.99

index

0.04

503

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

135

2.23

4.08

1.1

1.0

14.48

10.91

u/ml

0.21

(3023430) Cat dander IgE Ab [Units/volume] in Serum

593

1.56

4.04

1.1

3.70

3.54

u/ml

0.04

245

(3004809) Band form neutrophils/Leukocytes in Blood

563

1.58

4.00

4.9

3.4

1.76

1.52

0.16

511

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

628

1.54

3.96

2.0

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

136

957

1.44

3.93

1.9

2.4

0.00

g/l

-0.00

129

906

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.13

3.92

1.0

1.1

0.01

0.06

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

262

1.84

3.89

1.1

0.40

2.73

u/ml

1.00

(3014599) Egg white IgE Ab [Units/volume] in Serum

262

1.84

3.89

1.1

1.0

5.38

1.48

u/ml

0.37

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

552

1.57

3.87

1.5

1.3

0.60

3.80

nmol/l

0.50

534

(3023419) Bacteria identified in Sputum by Culture

468

1.61

3.80

2.5

2.7

—

(3022313) Gas panel - Capillary blood

195

1467

1.35

3.80

3.9

3.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

447

1.62

3.73

2.5

18.13

33.10

iu/ml

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

449

1.61

3.67

1.9

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

123

862

1.44

3.66

1.3

3.89

35.65

e6/l

2.47

632

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

552

1.55

3.65

1.1

1.0

0.33

0.17

u/ml

0.46

162

(3006571) Granulocytes/Leukocytes in Synovial fluid

404

1.64

3.62

1.5

1.6

52.29

57.83

0.46

250

(3019977) pH of Arterial blood

477

4027

1.21

3.61

7.2

8.0

7.42

0.00

285

2207

(3027801) Oxygen [Partial pressure] in Arterial blood

477

4028

1.21

3.60

7.1

8.0

11.98

12.67

kpa

2.56

455

3892

(3024354) Oxygen [Partial pressure] in Venous blood

344

2809

1.25

3.59

5.1

3.0

4.55

4.57

kpa

0.07

336

2732

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

643

1.50

3.59

1.4

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.95

3.57

1.0

1.1

2.36

1.12

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

596

1.52

3.55

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

419

3500

1.22

3.53

3.4

3.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

293

1.75

3.53

1.3

1.2

233.33

167.78

titre

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

774

6828

1.17

3.51

4.2

3.7

255.04

389.88

ng/l

1.14

541

4999

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

476

4029

1.21

3.51

7.2

8.0

5.02

5.09

kpa

1.04

452

3892

(3008295) Osmolality of Serum or Plasma

400

1.64

3.50

1.5

1.4

281.10

277.83

mosm/kgh2o

0.57

314

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.24

3.50

1.6

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

201

1539

1.32

3.50

5.6

1.63

1.61

0.17

190

1461

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

324

1.71

3.49

1.1

1.0

283.48

293.25

mg/l

0.26

297

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

3.62

3.49

1.0

0.02

1.11

u/ml

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.88

3.48

1.2

1.1

—

3.40

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

138

998

1.40

3.46

1.4

9.50

12.10

u/l

1.49

113

834

(4015189) Microbial culture of sputum

2.54

3.46

2.6

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1848

17297

1.13

3.44

3.0

2.7

—

estimate

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

577

1.52

3.42

1.1

119.00

117.80

0.13

530

(3016502) Oxygen saturation in Arterial blood

425

3567

1.21

3.42

7.4

8.3

95.93

95.83

0.13

411

3459

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

3.52

3.39

1.0

0.02

0.03

u/ml

—

(4268621) Lupus anticoagulant assay

435

1.60

3.39

2.3

—

(21494434) Karyotype in Bone marrow

297

1.73

3.38

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

579

1.51

3.37

1.9

1.7

—

(3003396) Base excess in Arterial blood by calculation

471

3999

1.20

3.36

7.1

7.9

0.87

0.90

mmol/l

0.04

365

3292

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

114

2.20

3.34

3.4

2.7

28.67

29.10

umol/l

0.07

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

162

1211

1.35

3.33

1.4

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

149

1102

1.37

3.28

3.9

2.4

3.52

3.57

g/l

0.18

143

1045

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

285

1.73

3.28

2.5

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

487

1.55

3.26

1.4

1.3

0.19

0.22

nmol/l

0.34

376

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

488

1.55

3.24

2.9

2.5

5.20

640.58

u/ml

0.64

482

(3047181) Lactate [Moles/volume] in Blood

144

1062

1.37

3.23

6.5

1.30

1.27

mmol/l

0.18

129

940

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

569

1.50

3.22

1.2

1.1

2.51

0.77

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

279

1.73

3.22

2.1

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

103

718

1.45

3.19

1.6

1.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.80

3.18

1.0

0.01

4.03

u/ml

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

122

879

1.40

3.16

1.4

277.02

1372.04

e6/l

2.08

686

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

222

1.81

3.14

1.1

1750.72

1420.20

miu/ml

1.16

222

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.26

3.13

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.26

3.13

1.1

—

(3003181) Sodium [Moles/volume] in Urine

663

1.46

3.13

1.4

61.47

61.82

mmol/l

0.03

536

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

168

1277

1.33

3.11

2.1

1.9

—

30.85

—

(3010503) CD19 cells [#/volume] in Blood

231

1.78

3.07

2.6

2.5

250.71

245.57

e6/l

0.01

223

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

866

7779

1.14

3.04

5.6

5.5

1.88

2.78

ug/l

3.73

776

7051

(3011897) Casein IgE Ab [Units/volume] in Serum

2.59

3.04

1.1

1.2

0.01

8.00

u/ml

0.50

(3028433) Virus identified in Specimen by Culture

106

2.18

3.02

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

126

2.07

3.02

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.34

3.01

1.0

0.01

0.11

u/ml

—

(3002032) Base excess in Venous blood by calculation

390

3294

1.20

2.96

5.9

3.7

1.61

1.81

mmol/l

0.49

345

2886

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

126

924

1.38

2.96

1.9

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

133

986

1.36

2.92

1.3

479.82

528.94

mg/l

0.83

126

939

(4024509) Urine culture

219

1741

1.27

2.92

2.1

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

154

1171

1.33

2.87

2.6

2.1

95.69

93.85

0.49

139

1132

(3039000) Anion gap in Blood by calculation

100

710

1.42

2.85

7.6

8.1

11.60

11.19

mmol/l

0.59

642

(3018572) Chloride [Moles/volume] in Blood

100

711

1.42

2.83

7.6

8.1

104.42

105.24

mmol/l

0.86

643

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

123

2.04

2.81

2.7

2.6

0.60

0.61

mmol/l

0.40

123

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.65

2.79

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

180

1407

1.29

2.76

6.0

5.9

0.89

0.90

0.07

170

1330

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

581

1.46

2.76

1.3

23.76

27.09

u/l

0.26

500

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

220

1764

1.26

2.75

5.9

2.8

0.59

0.62

0.87

220

1754

(3020911) Cortisol [Moles/time] in 24 hour Urine

138

1.96

2.74

1.8

1.3

1082.46

123.58

nmol/24h

0.45

138

(3036489) Thrombin time

179

1400

1.29

2.74

2.4

2.0

20.04

21.00

2.61

142

1230

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

100

716

1.41

2.73

1.4

31.77

29.46

u/l

0.25

593

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

177

1384

1.29

2.71

1.3

175.40

226.93

miu/ml

1.30

686

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

118

2.04

2.71

1.1

1.3

95.10

88.40

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

2.15

2.70

1.5

1.3

45.77

50.36

0.22

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

105

760

1.39

2.70

2.5

3.6

156.43

773.26

u/ml

1.05

700

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.51

2.70

2.4

9.2

69.70

69.90

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

6.01

2.70

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

6.01

2.70

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

423

3634

1.18

2.68

2.7

2.4

51.22

39.16

u/l

0.60

361

3059

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

376

1.55

2.61

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

186

1473

1.28

2.60

4.4

3.2

24.91

25.30

mmol/l

0.77

178

1413

(3045683) HLA typing for celiac disease panel - Blood or Tissue

244

1.69

2.59

1.0

—

(3049717) Cytology report of Urine Cyto stain

153

1183

1.30

2.57

2.7

2.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.42

2.53

1.9

2.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.42

2.53

1.0

0.82

5.81

u/ml

0.63

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

395

1.53

2.53

2.2

2.1

23.77

21.13

mg/l

0.22

142

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.27

2.50

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

147

1135

1.31

2.50

4.1

3.7

24.50

24.93

mmol/l

1.16

135

1047

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

122

1.97

2.50

1.8

1.9

1.17

1.19

ug/l

0.01

116

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

712

1.39

2.49

2.5

2.3

52.04

87.44

ug/min

0.86

428

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

172

1358

1.28

2.47

1.8

2.0

1.72

1.88

ug/l

0.09

151

1215

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

126

954

1.33

2.47

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

414

1.51

2.46

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

386

4471

0.85

2.44

1.9

3.53

3.41

ratio

0.97

284

3371

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

399

1.51

2.43

5.5

66.56

66.69

u/ml

0.00

128

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

448

1.48

2.42

2.1

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

219

1.70

2.41

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

141

1090

1.30

2.39

3.1

2.4

185.68

186.22

0.03

131

1042

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

6.26

2.37

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

118

1.95

2.35

1.1

—

6.80

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

175

1395

1.27

2.35

1.8

1.7

258.03

296.91

mu/l

1.58

159

1263

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

283

3351

0.83

2.32

1.7

3.50

mmol/l

0.02

180

2264

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

133

1.89

2.31

1.1

1.0

0.25

0.99

u/ml

0.57

133

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

324

2759

1.19

2.30

2.1

1.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

261

1.62

2.29

1.2

1.1

—

1.48

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

484

4259

1.15

2.29

5.1

4.8

32.11

32.57

0.43

367

2884

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

216

1770

1.23

2.28

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

120

1.92

2.25

1.1

89.20

88.52

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

120

1.92

2.25

2.1

1.4

—

(3012501) Base excess in Blood by calculation

709

1.36

2.24

3.8

4.2

1.96

2.57

mmol/l

1.73

485

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

217

1783

1.23

2.24

5.8

2.8

1.16

1.22

0.39

217

1771

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

149

1173

1.28

2.23

2.3

2.1

2.33

8.46

iu/l

0.75

512

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.20

1.4

1.2

90.00

76.86

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

389

3377

1.17

2.20

8.1

8.8

121.34

120.96

g/l

0.13

380

3307

(3001964) Herpes simplex virus Ag [Presence] in Specimen

100

2.00

2.20

2.5

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

304

1.55

2.18

4.6

3.1

45.25

37.20

mg/l

0.13

217

(3006922) Hepatitis E virus Ab [Presence] in Serum

305

1.55

2.16

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

394

1.48

2.16

1.3

1.2

52.43

56.27

u/l

0.37

348

(3022689) Creatine [Moles/volume] in Urine

122

1.89

2.15

2.3

1.5

7.56

7.67

mmol/l

0.03

122

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

219

1.65

2.15

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

562

1.40

2.13

1.1

4.46

2.90

—

103

(3017354) Segmented neutrophils/Leukocytes in Blood

363

1.49

2.12

4.4

3.5

59.96

57.13

0.44

318

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.21

2.10

1.1

0.59

0.71

umol/24h

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.21

2.10

1.3

1.1

10.81

7.35

mg/g

0.41

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

666

1.36

2.09

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1011

9362

1.11

2.07

4.5

4.0

91.61

92.26

0.36

975

9153

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

565

1.39

2.07

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

206

1.66

2.07

1.4

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

877

0.70

2.06

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

341

1.50

2.06

1.9

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

1.89

2.05

1.1

1.3

—

(3045142) Bone marrow Pathology biopsy report

407

1.46

2.05

1.5

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.00

2.04

2.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

154

1.76

2.03

2.1

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

748

1.33

2.02

3.3

2.8

35.84

34.98

umol/l

0.14

686

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.11

2.02

1.2

85.83

71.61

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

126

985

1.29

2.02

1.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.08

2.01

1.0

1.5

—

(3024263) Appearance of Synovial fluid

178

1.69

1.98

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.15

1.98

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.03

1.95

1.5

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.98

1.95

1.2

35.22

38.35

g/l

0.28

(3000012) Reticulocyte production index

462

1.41

1.94

1.9

2.2

1.01

0.90

0.82

312

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.57

1.94

1.0

1.1

0.04

0.03

u/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

2.73

1.93

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

842

0.71

1.93

1.5

1.16

1.28

1.65

589

(3022493) Free Hemoglobin [Mass/volume] in Plasma

142

1.77

1.92

1.0

5.3

48.06

62.32

mg/l

1.13

103

(3044290) Cell count panel - Cerebral spinal fluid

106

816

1.31

1.92

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1280

12033

1.09

1.90

2.5

2.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

251

1.56

1.89

1.1

6.94

7.97

nmol/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

228

1.58

1.87

1.3

1.2

72.13

81.68

u/l

0.52

193

(3051611) Lipemic interference index of Serum or Plasma

333

1.48

1.86

2.6

3.3

14.63

13.30

index

0.19

194

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

129

1.79

1.85

1.3

2.0

156.30

166.33

0.27

123

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.98

1.84

1.4

32.18

30.63

0.05

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

221

1.59

1.84

1.3

1.2

12.83

19.98

u/l

1.26

182

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

708

1.32

1.83

1.7

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1074

0.75

1.83

1.5

60.90

59.01

ug/l

0.15

883

(3018133) Calcium [Moles/volume] in Urine

2.13

1.81

1.2

1.7

2.18

3.29

mmol/l

2.16

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

183

1.64

1.81

1.3

4.59

4.80

umol/l

0.14

164

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

270

1.52

1.81

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

853

0.72

1.79

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

231

1.56

1.78

1.2

0.51

0.57

ratio

1.31

146

(3047007) Chlamydophila sp Ab [Presence] in Serum

582

1.35

1.77

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

129

1031

1.26

1.77

3.0

3.3

0.36

0.35

iu/ml

0.09

562

(44816559) Phosphatidylethanol [Mass/volume] in Blood

186

1547

1.21

1.76

1.5

1.6

0.33

mg/l

0.03

696

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

567

1.35

1.73

1.1

3.59

3.33

eliau/ml

0.08

273

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

209

1.58

1.73

1.5

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

257

1.52

1.73

7.4

8.43

99.24

ug/l

0.76

165

(3017704) Immunofixation for Urine

178

1.63

1.72

2.0

1.7

—

(44806420) Estimation of glomerular filtration rate

482

1.38

1.72

3.0

2.4

—

(4281824) Cell count and differential, peritoneal fluid

458

0.63

1.72

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

423

1.40

1.71

1.1

—

5.54

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

0.02

0.03

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

272

2348

1.17

1.71

2.4

3.5

39.16

62.05

u/ml

1.45

261

2266

(21494814) CD8 cells/Lymphocytes in Specimen

156

1.67

1.68

2.1

27.92

30.21

0.32

156

(44790047) Parainfluenza type 1 nucleic acid detection

467

1.38

1.68

2.1

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

467

1.38

1.68

2.1

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

467

1.38

1.68

2.1

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

467

1.38

1.68

2.1

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

366

1.43

1.68

2.5

4.4

7.16

7.27

mmol/l

0.09

306

(44806071) Cardiolipin IgM antibody measurement

2.19

1.67

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

214

0.47

1.67

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

3.16

1.66

1.5

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

220

1.55

1.64

1.6

1.4

11.97

13.15

u/l

0.48

211

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

182

1.60

11.1

6.0

32.50

53.18

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.07

1.59

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.07

1.59

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.07

1.59

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

121

1.74

1.58

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

397

1.39

1.56

1.5

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

247

2134

1.17

1.56

6.1

3.1

132.00

129.17

g/l

1.24

239

2070

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.28

1.55

2.8

3.3

—

31.90

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

168

1.61

1.54

1.1

129.55

184.18

iu/ml

1.31

168

(3036525) Urea [Moles/time] in 24 hour Urine

3.34

1.52

3.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

366

1.40

1.51

1.5

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

366

1.40

1.51

1.4

1.85

1.47

nmol/l

1.29

336

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

591

1.31

1.49

1.1

63.27

19191.07

iu/ml

0.53

122

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

367

1.39

1.49

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

173

1457

1.20

1.48

1.8

1.7

4.28

4.33

mg/l

0.03

147

1073

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

697

1.28

1.48

1.2

1.1

2.12

17.60

au/ml

8.29

182

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.23

1.46

14.4

11.7

4.54

5.48

mmol/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.23

1.46

2.4

0.58

1.32

mmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.37

1.45

1.2

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

1.45

1.1

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

348

3101

1.13

1.44

8.2

7.7

1.27

1.31

mmol/l

0.29

336

3045

(3008757) Leukocyte morphology finding [Identifier] in Blood

345

1.40

1.42

4.4

4.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

998

0.78

1.42

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

507

0.69

1.42

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.82

1.41

1.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

624

5752

1.10

1.41

4.0

2.9

2.74

3.07

e6/l

0.21

306

2740

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

1.70

1.41

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.18

1.39

1.3

1.5

—

(40768800) Prostate Pathology biopsy report

517

0.69

1.39

1.1

1.2

—

(4035726) Immunohistochemistry procedure

362

3243

1.13

1.38

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

142

1.62

1.38

1.2

1475.00

956.67

titre

—

(40768441) Liver Pathology biopsy report

289

1.42

1.36

1.4

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.33

0.0

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

462

1.33

1.32

6.6

6.5

11.88

11.95

mg/l

0.04

433

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

325

1.39

1.31

1.2

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

121

1.66

1.30

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.50

1.30

1.0

0.05

0.08

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

377

1.36

1.30

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1007

0.79

1.30

1.4

1.5

1.07

1.18

ratio

0.75

599

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1007

0.79

1.30

1.4

1.5

0.91

0.95

ratio

0.58

597

(3044927) Protein electrophoresis panel - Urine

326

1.38

1.29

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

658

1.27

1.29

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1005

0.79

1.28

1.4

1.5

0.99

1.14

ratio

1.28

595

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

310

1.39

1.28

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

310

1.39

1.28

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

310

1.39

1.28

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

674

6267

1.09

1.27

5.0

4.5

22.44

21.77

0.56

326

3028

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

235

1.45

1.27

1.6

1.5

—

(21494755) Public health laboratory ask at order entry panel

333

3703

0.89

1.26

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.82

1.25

13.0

7.8

6.00

5.38

kpa

0.42

(3023511) Choriogonadotropin [Units/volume] in Urine

796

1.24

1.25

1.6

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

406

1.33

1.25

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

146

1235

1.19

1.24

1.5

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

321

1.37

1.23

3.2

3.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.04

1.22

2.1

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.63

1.21

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

0.00

0.03

u/ml

—

(3025577) Chromium [Mass/volume] in Blood

180

1.50

1.20

2.3

2.2

3.77

2.58

ug/l

0.64

152

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

172

1.51

1.20

1.8

1.91

2.91

u/field

0.40

127

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

231

1.43

1.17

1.1

0.89

1.14

u/l

4.64

106

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

141

1.56

1.17

3.5

3.1

1.09

1.19

0.17

141

(4034850) Laboratory test

132

1114

1.19

1.16

10.8

9.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.77

1.16

2.7

2.5

52.86

48.57

ug/l

0.02

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

190

1.48

1.16

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

438

1.31

1.15

1.1

101.43

97.65

0.41

414

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.05

1.15

1.0

1.1

1.46

1.72

umol/24h

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.15

3.0

5.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

742

1.23

1.14

1.6

—

(3016228) CD19 cells/cells in Blood

158

1.52

1.14

2.1

2.0

11.71

7.20

0.69

152

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

154

0.52

1.13

2.1

2.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.75

1.12

1.0

2.1

1.66

2.01

ug/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.34

1.12

1.4

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.00

1.12

1.4

2.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

103

1237

0.83

1.11

1.3

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

101

837

1.21

1.09

2.0

2.3

128.11

129.13

g/l

0.15

664

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

201

1.45

1.09

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

168

1.49

1.09

1.8

1.4

142.16

155.37

mmol/24h

0.38

168

(3000330) Specific gravity of Urine by Test strip

153

1772

0.86

1.09

4.4

3.3

1.02

ratio

1.22

132

1605

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

459

4229

1.10

1.08

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

235

1.41

1.08

1.6

1.5

5.62

5.56

u/l

0.01

193

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

157

1355

1.17

1.08

1.8

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

269

1.38

1.08

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

210

1.43

1.08

1.1

1.4

141.53

132.74

nmol/l

0.38

210

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

270

1.37

1.06

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

288

1.36

1.04

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.27

1.03

1.8

1.6

320.20

327.27

umol/24h

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

332

1.33

1.03

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

447

1.28

1.02

1.2

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

224

1994

1.13

1.01

10.1

10.6

15.74

15.95

0.51

214

1925

(3052592) Norovirus Ag [Presence] in Stool

1.89

1.01

1.2

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.88

1.00

1.3

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

3.8

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

163

1861

0.87

0.98

1.5

1.6

999.31

1021.72

mu/l

0.13

144

1534

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

283

1.35

0.98

1.4

398.24

365.99

u/l

0.12

273

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

1.52

0.97

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

124

1.53

0.96

1.3

1.4

132.60

123.31

nmol/l

0.08

(1002224) Polysomnography panel

212

1888

1.13

0.96

1.1

—

(3023410) Appearance of Cerebral spinal fluid

399

1.28

0.94

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

110

1288

0.85

0.93

1.4

2.2

—

(3001729) Color of Synovial fluid

2.22

0.93

1.8

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

175

1.43

0.92

1.2

1.4

—

(40765096) Chromosome analysis panel by Banding

118

1.53

0.90

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

168

1.43

0.89

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

168

1.43

0.89

1.7

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.69

0.88

3.5

2.3

—

(3016750) Collection duration of Urine

177

1.41

0.88

2.2

2.3

513.38

487.76

min

0.77

131

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.79

0.87

8.4

7.4

10.96

10.72

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

203

1.38

0.87

1.3

1.2

6.14

9.22

mm/h

2.16

203

(3042517) Benzodiazepines panel - Urine

2.00

0.87

1.2

2.2

—

(3006270) Folate [Moles/volume] in Blood

281

1.32

0.86

1.3

1.1

359.48

386.24

nmol/l

0.44

251

(3022621) pH of Urine by Test strip

323

2966

1.10

0.86

2.8

2.5

6.02

6.09

0.69

204

1942

(3027944) Amphetamines [Presence] in Urine

120

1383

0.86

0.85

1.4

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

946

1.17

0.84

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.59

0.84

1.1

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.88

0.81

1.0

1.2

3.50

18.84

u/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

710

1.19

0.80

3.8

3.4

21.20

25.46

mg/l

0.82

491

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.79

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

173

1.39

0.78

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

675

1.19

0.78

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

675

1.19

0.78

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

474

1.23

0.78

1.7

1.5

23.20

25.59

ng/l

0.34

474

(3008536) Aspergillus sp Ab [Presence] in Serum

1.62

0.78

1.7

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.51

0.77

1.6

3.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

305

1.28

0.76

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

227

1.32

0.74

1.8

98.41

104.13

ng/l

0.17

227

(3028707) Methadone [Presence] in Urine by Screen method

602

0.81

0.74

1.5

2.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

496

1.21

0.74

1.3

7.42

7.34

mmol/l

0.06

444

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

717

1.18

0.73

3.6

2.1

0.85

0.84

nmol/l

0.02

614

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

231

0.69

0.73

1.5

1.7

—

(3028300) Cannabinoids [Presence] in Urine

124

1405

0.88

0.72

1.4

2.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

176

1.37

0.72

1.2

1.4

5.67

4.15

—

(3000764) Benzodiazepines [Presence] in Urine

123

1392

0.88

0.71

1.4

2.1

—

(3000991) Gas panel - Venous blood

318

2950

1.08

0.71

10.3

9.0

—

(3001556) Androgen free Index in Serum or Plasma

1.92

0.70

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

139

1236

1.13

0.70

1.8

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

739

1.17

0.70

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.51

0.69

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

124

1399

0.88

0.69

1.4

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.53

0.69

1.3

—

(1761868) Lipid panel - Serum or Plasma

1538

14968

1.04

0.68

3.4

3.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

741

1.16

0.68

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

184

1667

1.11

0.68

1.3

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

1.53

0.68

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.60

0.68

1.6

3.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

125

1408

0.88

0.68

1.1

0.63

ratio

0.02

186

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

127

1.42

0.67

2.3

2.0

1.62

1.71

ratio

0.09

121

(4212803) Bone marrow aspirate examination

1.79

0.66

1.4

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

145

1300

1.12

0.65

3.4

3.5

83.33

1387.78

u/ml

1.05

126

1122

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.61

0.65

1.2

3.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

231

2124

1.09

0.64

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3063

30276

1.05

0.64

25.4

19.2

332.00

331.92

g/l

0.19

3049

30116

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

416

1.20

0.61

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

495

4697

1.06

0.61

3.5

3.2

0.72

0.76

ug/l

0.34

322

3056

(4198724) Urine methamphetamine measurement

137

0.66

0.60

1.6

3.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.53

0.59

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

241

0.75

0.56

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.46

0.56

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

108

964

1.12

0.55

1.2

—

(3012898) Urea [Moles/volume] in Urine

1.62

0.55

1.0

1.4

143.98

140.81

mmol/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

107

1.40

0.55

1.6

0.46

0.49

e9/l

0.27

107

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

159

1.32

0.55

1.0

1.1

32.02

421.02

ng/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

391

3703

1.06

0.53

3.5

4.2

8.04

28.73

ug/l

1.39

295

2945

(3004775) Volume in Urine collected for unspecified duration

241

1.25

0.52

2.4

2.3

744.90

598.67

0.90

161

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

192

0.73

0.52

1.2

3.3

—

(3014271) Vancomycin [Susceptibility]

126

1.35

0.51

3.3

3.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.39

0.49

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

316

1.20

0.49

2.6

2.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

890

0.89

0.48

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

172

1.28

0.48

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

190

1.26

0.48

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

190

1.26

0.48

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

190

1.26

0.48

1.6

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

190

1.26

0.48

1.6

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

128

1.33

0.47

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.49

0.47

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

137

1.32

0.47

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

137

1.32

0.47

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.46

0.46

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

328

1.19

0.46

1.4

12692.67

89561.48

e6/l

2.03

178

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

246

1.22

0.45

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

238

1.22

0.44

1.3

1.4

76.34

77.61

umol/l

0.10

238

(1001926) Buprenorphine [Presence] in Urine by Screen method

100

1103

0.90

0.43

1.4

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

592

1.13

0.43

2.9

3.4

0.83

0.81

nmol/l

0.10

482

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

1.35

0.43

2.6

2.8

9.45

10.59

kpa

0.63

104

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

1.35

0.43

2.6

2.8

4.78

4.80

kpa

0.03

104

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.61

0.43

1.6

1.5

42.20

45.13

umol/l

—

(3016038) Potassium [Moles/volume] in Urine

239

1.21

0.42

1.2

1.1

34.63

34.99

mmol/l

0.02

212

(3013862) HLA-DP [Type]

0.00

0.41

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.41

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.41

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.41

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.41

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

4.9

—

3.12

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

520

1.14

0.41

1.2

1.5

2.26

3.84

ug/l

1.83

458

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.40

0.0

2.1

—

(3034426) Prothrombin time (PT)

123

1.30

0.40

1.2

29.19

28.54

0.19

123

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.47

0.40

1.2

2.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.39

2.0

1.2

5.14

5.85

mmol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.39

0.0

2.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

400

1.15

0.38

1.6

1.9

14.31

24.38

ug/l

2.46

394

(3024891) Influenza virus A+B Ag [Presence] in Specimen

111

1019

1.09

0.38

1.1

—

(40757373) Influenza virus identified in Isolate

1.36

0.38

3.0

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

333

0.84

0.37

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.35

0.37

1.0

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.31

0.37

1.7

1.4

12.44

23.07

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.29

0.36

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

234

2218

1.06

0.35

1.8

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.35

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.36

0.34

4.5

9.6

0.18

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1.23

0.33

2.0

1.9

40.68

40.62

g/l

0.01

154

(40765089) Chromosome analysis panel - Blood by G-banded

1.32

0.33

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.32

0.33

1.0

28.22

37.21

iu/ml

0.22

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

145

1.24

0.33

1.8

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

145

1.24

0.33

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

145

1.24

0.33

1.7

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

237

1.18

0.33

1.0

404.68

319.88

ng/l

0.53

167

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

133

0.75

0.33

2.2

2.5

130.10

149.01

nmol/l

—

119

(3012441) Differential panel - Pleural fluid

312

1.16

0.33

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

238

1.18

0.32

1.0

778.86

722.86

ng/l

0.25

163

(3023199) Leukocytes [#/volume] in Pleural fluid

379

1.14

0.32

1.4

1.5

2364.89

4450.78

e6/l

0.40

263

(3005011) Chlamydia sp Ab [Titer] in Serum

1.30

0.30

2.1

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

296

1.15

0.30

3.4

2.6

20.50

28.40

mg/l

0.97

210

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

240

1.17

0.30

1.0

54.18

43.25

ng/l

0.42

165

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.27

0.30

1.1

—

(3025130) Human papilloma virus identified in Specimen

738

1.09

0.28

1.7

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

448

0.89

0.27

1.8

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

196

1.17

0.27

1.3

—

(3020491) Glucose [Moles/volume] in Blood

262

1.15

0.26

2.1

1.6

6.67

6.63

mmol/l

0.03

179

(3036071) Salmonella sp Ab [Titer] in Serum

141

1.21

0.26

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.32

0.23

1.4

1.1

128.00

88.42

titre

—

(4133840) Spirometry

0.76

0.22

1.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

200

1.15

0.22

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

276

1.12

0.22

1.0

1.1

15.50

16.61

u/ml

—

126

(3027923) C peptide [Moles/volume] in Serum or Plasma

210

1.14

0.21

1.8

1.4

1.20

1.25

nmol/l

0.08

158

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

289.09

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

927

9126

1.02

0.21

2.4

2.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.21

1.2

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

298

1.11

0.19

1.1

4.67

8.33

iu/ml

1.04

(3001186) Copper [Moles/volume] in Serum or Plasma

122

0.82

0.19

1.1

1.3

16.90

16.76

umol/l

—

106

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

214

2072

1.03

0.17

8.5

9.8

24.30

24.26

mmol/l

0.06

208

2042

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

163

0.86

0.17

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

186

1.13

0.17

1.2

1.3

—

70.41

—

(3011288) Drugs identified in Urine by Screen method Nominal

997

0.95

0.16

1.7

2.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.20

0.16

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.21

0.15

1.6

1.2

4.76

451.64

ug/l

—

(40768793) Breast Pathology biopsy report

115

1105

1.04

0.14

1.3

—

(3017569) Oxygen content in Arterial blood

198

1.11

0.14

2.5

2.3

16.67

16.24

0.23

198

(3041354) Potassium [Moles/volume] in Venous blood

347

0.92

0.14

4.0

2.3

3.92

4.01

mmol/l

0.61

342

(3035285) Chloride [Moles/volume] in Venous blood

347

0.92

0.14

4.0

2.3

106.69

105.53

mmol/l

0.81

342

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

103

1.17

0.13

1.1

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

287

1.08

0.12

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

104

1.15

0.12

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

1082

10729

1.01

0.11

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

680

0.96

0.11

1.4

1.5

60.26

60.46

ug/l

0.01

680

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

163

1.10

0.10

1.3

1.4

198.62

209.51

pmol/l

0.07

163

(3033705) Calcium.ionized [Moles/volume] in Venous blood

341

0.94

0.10

4.0

2.4

1.20

mmol/l

0.32

336

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.14

0.10

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

106

1.13

0.09

1.8

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

1.09

0.09

4.0

6.7

8.70

8.62

mmol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.06

0.09

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.77

0.08

1.2

1.1

6.36

8.03

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

105

1023

1.03

0.08

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

551

0.96

0.08

1.6

1.5

—

(4211845) Urine protein measurement

174

0.92

0.07

4.9

3.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.04

0.07

1.0

1.3

1.19

mmol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

772

0.97

0.07

1.8

—

(3044007) Cell count panel - Peritoneal fluid

118

1.10

0.07

2.3

2.0

—

(3020650) Glucose [Presence] in Urine

128

1.09

0.06

1.2

1.9

0.00

0.02

estimate

0.50

128

(3004451) EKG impression Narrative

203

0.94

0.06

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

1.08

0.04

1.6

2.0

3955.14

20459.32

e6/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

755

1.02

0.04

4.9

4.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.09

0.04

1.1

—

(3045788) Cell count panel - Pleural fluid

319

1.03

0.03

1.3

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

118

0.93

0.02

1.2

—

6.85

—

(40768806) Pleura Pathology biopsy report

322

1.03

0.01

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

739

0.99

0.01

1.5

1.4

0.30

0.40

nmol/l

0.87

560

(40768795) Lymph node Pathology biopsy report

367

0.98

0.01

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

254

1.02

0.00

1.0

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

484

1.01

0.00

4.2

5.8

335.44

367.46

umol/l

0.80

428

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

168

1.01

0.00

1.4

2.3

59.75

159.80

umol/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.05

0.00

1.7

1.5

2.70

3.10

mmol/l

—

(4146454) Self-monitoring of blood glucose

349

1.00

0.00

2.8

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

266

1.02

0.00

1.9

2.0

4.00

1.59

u/field

0.92

145

(3006462) Nitrate [Presence] in Urine

156

1.03

0.00

4.9

3.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

2.30

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

0.26

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2913.25

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

25.08

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

8102.50

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.88

-0.00

1.2

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.00

-0.00

1.7

2.1

14.74

18.37

umol/l

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40758292) HTLV I+II Ab panel - Serum

0.99

-0.00

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.92

-0.00

1.2

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.99

-0.00

2.3

3.5

59.71

1310.32

u/l

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

2.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

110

1.00

-0.00

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.88

-0.00

1.2

1.3

56.67

66.31

ug/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

200

1.00

-0.00

1.9

2.1

7.27

8.44

mmol/l

1.17

200

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.40

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.90

-0.00

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ROSACEANAS and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_ROSACEANAS	1.025 [0.91, 1.15]	0.679
Birth year	0.993 [0.98, 1.0]	0.116

During the follow-up period (1.1.1998 — 31.12.2019), 841 out of 9572 females with L12_ROSACEANAS died.

Males

Parameter	HR [95% CI]	p-value
L12_ROSACEANAS	1.159 [1.02, 1.31]	0.02
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 934 out of 4958 males with L12_ROSACEANAS died.

Mortality risk

Mortality risk for people of age

years, who have L12_ROSACEANAS.

N-year risk	Females	Males
1	0.13%	0.201%
5	0.63%	1.099%
10	1.48%	2.94%
15	3.042%	5.396%
20	4.96%	9.137%

Relationships between endpoints

↥

Index endpoint: L12_ROSACEANAS – Other and unspecified rosacea

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified rosacea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints